Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

Articles published in
Br J Dermatol
    September 2021
  1. POSPISCHIL I, Guenova E
    Mycosis fungoides-derived exosomes and their microRNA-1246 cargo: a message from the skin.
    Br J Dermatol. 2021 Sep 14. doi: 10.1111/bjd.20695.
    >> Share

  2. ULRIKSDOTTER J, Svedman C, Bruze M, Mowitz M, et al
    Allergic contact dermatitis caused by dipropylene glycol diacrylate in the Omnipod(R) insulin pump.
    Br J Dermatol. 2021 Sep 12. doi: 10.1111/bjd.20751.
    >> Share

  3. MAEDA T, Hiura A, Uehara J, Toyoshima R, et al
    Combined carboplatin and paclitaxel therapy improves overall survival in patients with nivolumab-resistant acral and mucosal melanoma.
    Br J Dermatol. 2021 Sep 12. doi: 10.1111/bjd.20758.
    >> Share

  4. ZHEN Q, Zhang Y, Yu Y, Yang H, et al
    Three Novel Structural Variations at MHC and IL12B Predisposing to Psoriasis.
    Br J Dermatol. 2021 Sep 9. doi: 10.1111/bjd.20752.
    >> Share

  5. FORSYTH JR, Russell E, McPherson T
    A retrospective case series of paediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: evaluation of practice using the British Association of Dermatology's National Guidelines for children and young people.
    Br J Dermatol. 2021 Sep 4. doi: 10.1111/bjd.20741.
    >> Share

  6. DING J, Joseph M, Yau N, Khosa F, et al
    Underreporting of race and ethnicity in pediatric atopic dermatitis clinical trials: A cross-sectional analysis of demographic reporting and representation.
    Br J Dermatol. 2021 Sep 4. doi: 10.1111/bjd.20740.
    >> Share

  7. BURDEN-THE E, Murphy R, Gran S, Nijsten T, et al
    Identifying the best predictive diagnostic criteria for psoriasis in children (<18 years): A UK multicenter case-control diagnostic accuracy study (DIPSOC study).
    Br J Dermatol. 2021 Sep 3. doi: 10.1111/bjd.20689.
    >> Share

  8. RA AG, Ho B, Bickerstaffe L, Bewley A, et al
    More than skin deep: a survey of the real-life experiences of acne vulgaris.
    Br J Dermatol. 2021 Sep 2. doi: 10.1111/bjd.20737.
    >> Share

  9. MONCRIEFF MD, Nobes JP
    Commentary on the British Association of Dermatologists UK basal cell carcinoma guidelines 2021: all together now ....
    Br J Dermatol. 2021 Sep 2. doi: 10.1111/bjd.20694.
    >> Share


  10. 19th Congress - European Society for Dermatology and Psychiatry (ESDaP) & 2nd Brain Skin Colloquium Conference. 11(th) - 12(th) June 2021.
    Br J Dermatol. 2021;185:e70-e156.
    >> Share

  11. HEPPT MV, Steeb T, Berking C
    Another step on the road towards standardized outcome reporting for congenital melanocytic naevi: one more to go!
    Br J Dermatol. 2021 Sep 1. doi: 10.1111/bjd.20691.
    >> Share

    August 2021
  12. GONZALEZ JM, Reed SD, Johnson FR
    Stratified psoriasis treatment plans: why is patient preference information needed?
    Br J Dermatol. 2021 Aug 31. doi: 10.1111/bjd.20697.
    >> Share

  13. BORTOLUZZI P, Ferrucci S, Galimberti D, Garavelli F, et al
    New insights on ocular surface disease in atopic dermatitis patients treated with dupilumab.
    Br J Dermatol. 2021 Aug 25. doi: 10.1111/bjd.20706.
    >> Share

  14. TRUM NA, Zain J, Martinez XU, Parekh V, et al
    Mogamulizumab Efficacy is Underscored by its Associated Rash that Mimics Cutaneous T-cell Lymphoma: A Retrospective Single-Centre Case Series.
    Br J Dermatol. 2021 Aug 24. doi: 10.1111/bjd.20708.
    >> Share

  15. LANGTON AK, Watson REB
    Identification of novel skin ageing genes: evidence from across the pigmentary continuum.
    Br J Dermatol. 2021 Aug 18. doi: 10.1111/bjd.20636.
    >> Share

  16. CUST AE
    Strengthening melanoma prevention and early detection among people with type 2 diabetes.
    Br J Dermatol. 2021 Aug 18. doi: 10.1111/bjd.20633.
    >> Share

  17. STANDL M
    Addressing the causality of the association of atopic dermatitis with depression and anxiety using Mendelian randomization.
    Br J Dermatol. 2021 Aug 17. doi: 10.1111/bjd.20622.
    >> Share

  18. VAN DE KERKHOF PCM
    The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis.
    Br J Dermatol. 2021 Aug 17. doi: 10.1111/bjd.20624.
    >> Share

  19. COOK S, Bajwa D, Hollestein L, Husain A, et al
    A 5-year retrospective review of skin adnexal tumours received at a tertiary dermatopathology service: Implications for linked genetic diagnoses.
    Br J Dermatol. 2021 Aug 13. doi: 10.1111/bjd.20701.
    >> Share

  20. WAN J, Abuabara K
    Growing evidence for an association between inflammatory skin disease and chronic kidney disease.
    Br J Dermatol. 2021 Aug 11. doi: 10.1111/bjd.20632.
    >> Share

  21. JACOBY TV, Chang MS, Thompson LL, Foreman RK, et al
    Histopathologically-confirmed lichenoid eruptions from immune checkpoint inhibitor therapy: A retrospective cohort analysis.
    Br J Dermatol. 2021 Aug 10. doi: 10.1111/bjd.20698.
    >> Share

  22. ZHAO Y, Wu L, Lu Q, Gao X, et al
    The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Br J Dermatol. 2021 Aug 6. doi: 10.1111/bjd.20690.
    >> Share

  23. DE BRITO M, Stevens BR, Yiu ZZN
    Can artificial intelligence be used for accurate remote scoring of the Psoriasis Area and Severity Index (PASI) in adult patients with plaque psoriasis? A Critically Appraised Topic.
    Br J Dermatol. 2021 Aug 5. doi: 10.1111/bjd.20663.
    >> Share

  24. SIL A, Panigrahi A, Pramanik JD
    Isolated cutaneous larva migrans over the scalp in a hod carrier.
    Br J Dermatol. 2021 Aug 3. doi: 10.1111/bjd.20589.
    >> Share

  25. VAN DER SCHOOT LS, van den Reek JMPA
    Data-driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine.
    Br J Dermatol. 2021 Aug 1. doi: 10.1111/bjd.20625.
    >> Share

  26. CARBALLIDO VAZQUEZ AM, Morgado B
    Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
    Br J Dermatol. 2021;185:e34.
    >> Share

  27. TSAO H
    Melanoma medicine in the new millennium.
    Br J Dermatol. 2021;185:239-240.
    >> Share

    July 2021
  28. XIE H, Zhou L, Liu F, Long J, et al
    Autophagy induction regulates aquaporin 3-mediated skin fibroblasts aging.
    Br J Dermatol. 2021 Jul 28. doi: 10.1111/bjd.20662.
    >> Share

  29. YOUSAF M, Ayasse M, Ahmed A, Gwillim E, et al
    Association between Atopic Dermatitis and Hypertension: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2021 Jul 28. doi: 10.1111/bjd.20661.
    >> Share

  30. PENSO L, Dray-Spira R, Weill A, Zureik M, et al
    Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1,326,312 patients in France.
    Br J Dermatol. 2021 Jul 26. doi: 10.1111/bjd.20659.
    >> Share

  31. DATZMANN T, Schoffer O, Meier F, Seidler A, et al
    Patients benefit from participating in the German skin cancer screening program? A large cohort study based on administrative data.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20658.
    >> Share

  32. GONDO GC, Merola JF, Bell S, Blauvelt A, et al
    Decreased quality of life in people with psoriasis and psoriatic arthritis versus people with psoriasis alone: data from a national US survey.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20657.
    >> Share

  33. SAEKI H, Baba N, Ito K, Yokota D, et al
    Difamilast ointment, a selective phosphodiesterase 4 inhibitor, in paediatric patients with atopic dermatitis: A phase 3 randomised double-blind, vehicle-controlled trial.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20655.
    >> Share

  34. WHITE JML, Lui H, Chute CG, Jakob R, et al
    The WHO ICD-11 Classification of Dermatological Disorders: a new comprehensive online skin disease taxonomy designed by and for dermatologists.
    Br J Dermatol. 2021 Jul 21. doi: 10.1111/bjd.20656.
    >> Share

  35. AFRA TP, Siraj MM, Razmi T M
    Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations': reply from authors.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20638.
    >> Share

  36. STOER NC, Botteri E, Busund M, Ghiasvand R, et al
    Menopausal hormone therapy and risk of melanoma: a population-based cohort study.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20640.
    >> Share

  37. VURAL S, Kerl K, Dogan PE, Vollmer S, et al
    Lesional activation of Tc 17 cells in Behcet's disease and psoriasis supports HLA-class I-mediated autoimmune responses.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20643.
    >> Share

  38. NAVRAZHINA K, Renert-Yuval Y, Frew JW, Grand D, et al
    Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20642.
    >> Share

  39. CATALA A, Munoz-Santos C, Galvan-Casas C, Roncero Riesco M, et al
    Cutaneous reactions after SARS-COV-2 vaccination: A cross-sectional Spanish nationwide study of 405 cases.
    Br J Dermatol. 2021 Jul 13. doi: 10.1111/bjd.20639.
    >> Share

  40. SCATOLINI M, Patel A, Grosso E, Mello-Grand M, et al
    GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma.
    Br J Dermatol. 2021 Jul 8. doi: 10.1111/bjd.20629.
    >> Share

  41. SCHNEIDER AM, Nelson AM
    Food for thought: does host diet affect skin microbes?
    Br J Dermatol. 2021 Jul 8. doi: 10.1111/bjd.20573.
    >> Share

  42. GAMBICHLER T, Boms S, Hessam S, Tischoff I, et al
    Primary cutaneous anaplastic large cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20630.
    >> Share

  43. PATHMARAJAH P, Gkini MA, Fox H, Muralidharan V, et al
    Patients with nodular prurigo commonly have pre-existing psychological disease which requires treatment concomitant with cutaneous treatments.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20627.
    >> Share

  44. VITALI F, Colucci R, Di Paola M, Pindo M, et al
    Early melanoma invasivity correlates with gut fungal and bacterial profiles.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20626.
    >> Share

  45. HOLLESTEIN LM, Arnspang Pedersen S
    Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?
    Br J Dermatol. 2021 Jul 5. doi: 10.1111/bjd.20526.
    >> Share

  46. CHEN CB, Chung WH
    Current agreement on the management of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2021 Jul 5. doi: 10.1111/bjd.20515.
    >> Share

  47. VOLC-PLATZER B
    Fumaric acid esters for paediatric psoriasis.
    Br J Dermatol. 2021;185:5-6.
    >> Share


  48. Ceramide kinase-like protein promotes cutaneous squamous cell carcinoma.
    Br J Dermatol. 2021;185:e4-e33.
    >> Share

  49. NIJSTEN T, Silverberg J, Gisondi P, Vestergaard C, et al
    Considerations in association studies in dermatoepidemiology.
    Br J Dermatol. 2021;185:1-2.
    >> Share

  50. HAMBLY R, Kirby B
    Biologic survival in hidradenitis suppurativa: much done, more to do.
    Br J Dermatol. 2021;185:16-17.
    >> Share

  51. MURRELL DF, Paul CF
    What instruments should we add to our toolbox for measuring the severity and control of eczema?
    Br J Dermatol. 2021;185:13-14.
    >> Share

  52. GIAMARELLOS-BOURBOULIS EJ
    Neutrophil trafficking: the missing link in the pathogenesis of hidradenitis suppurativa.
    Br J Dermatol. 2021;185:15-16.
    >> Share

  53. MAHMOUDI H, Nili A, Salehi Farid A, Tavakolpour S, et al
    Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption.
    Br J Dermatol. 2021;185:e2.
    >> Share

  54. ORENSTEIN LAV
    Elevated body mass index, a risk factor or consequence of hidradenitis suppurativa?
    Br J Dermatol. 2021;185:6-7.
    >> Share

  55. DUARTE B, Paiva Lopes MJ
    Response to: 'Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab'.
    Br J Dermatol. 2021;185:235-236.
    >> Share

  56. THOMPSON AM, Fernandez JM, Rick J, Hendricks AJ, et al
    Identifying triggers for hidradenitis suppurativa flare: a patient survey.
    Br J Dermatol. 2021;185:225-226.
    >> Share

  57. COYER F
    Silicone adhesive multilayered foam dressings for pressure ulcer prevention.
    Br J Dermatol. 2021;185:4-5.
    >> Share

  58. SORIANO LF, Chowdhury MMU, Cooper SM, Cousen P, et al
    Current prevalence and relevance of positive patch test reactions to cosmetic and noncosmetic isothiazolinones in the UK.
    Br J Dermatol. 2021;185:223-225.
    >> Share

  59. YOO DS, Lee JH, Kim SC, Kim JH, et al
    Mortality and clinical response of patients with bullous pemphigoid treated with rituximab.
    Br J Dermatol. 2021;185:210-212.
    >> Share

  60. LIU KX, Huang V, Chen CA, Elco CP, et al
    Longitudinal multicentre retrospective cohort study of treatment outcomes in extramammary Paget disease.
    Br J Dermatol. 2021;185:219-221.
    >> Share

  61. PRENS LM, Bouwman K, Aarts P, Arends S, et al
    Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study.
    Br J Dermatol. 2021;185:177-184.
    >> Share

  62. BETTOLI V, Toni G, Odorici G, Forconi R, et al
    Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa in patients of paediatric age: a pilot prospective study.
    Br J Dermatol. 2021;185:216-217.
    >> Share

  63. QUINN G, MacEochagain C, Mac Mahon J, Killion L, et al
    Actinic keratoses: pain severity after cryotherapy and patient tolerability of treatment.
    Br J Dermatol. 2021;185:234-235.
    >> Share

  64. WOLK K, Brembach TC, Simaite D, Bartnik E, et al
    Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
    Br J Dermatol. 2021;185:164-176.
    >> Share

  65. THOMAS KS, Apfelbacher CA, Chalmers JR, Simpson E, et al
    Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
    Br J Dermatol. 2021;185:139-146.
    >> Share

  66. HUGHES AJ, Tawfik SS, Baruah KP, O'Toole EA, et al
    Tape strips in dermatology research.
    Br J Dermatol. 2021;185:26-35.
    >> Share

  67. WRIGHT S, Strunk A, Garg A
    Trends in body mass index before and after diagnosis of hidradenitis suppurativa.
    Br J Dermatol. 2021;185:74-79.
    >> Share

  68. BEECKMAN D, Fourie A, Raepsaet C, Van Damme N, et al
    Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial.
    Br J Dermatol. 2021;185:52-61.
    >> Share

  69. VAN ZUUREN EJ, Arents BWM, Miklas M, Schoones JW, et al
    Identifying and appraising patient-reported outcome measures on treatment satisfaction in acne: a systematic review.
    Br J Dermatol. 2021;185:36-51.
    >> Share

    June 2021
  70. KIM M, Park HE, Han K, Lee J, et al
    Risk of Psoriasis among Survivors of Adult-onset Cancer: A Nationwide Population-based Cohort Study.
    Br J Dermatol. 2021 Jun 30. doi: 10.1111/bjd.20610.
    >> Share

  71. ALTAYEB A, Dawood S, Atwan A, Mills C, et al
    Teledermoscopy: A Helpful Detection Tool for Amelanotic and Hypomelanotic Melanoma.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20609.
    >> Share

  72. HARGADON KM
    The Role of Interferons in Melanoma Resistance to Immune Checkpoint Blockade: Mechanisms of Escape and Therapeutic Implications.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20608.
    >> Share

  73. EGEBERG A, Meteran H, Gyldenlove M, Zachariae C, et al
    Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20602.
    >> Share

  74. O'KANE D, McCourt C, Meggitt S, D'Cruz DP, et al
    British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus (CLE) 2021.
    Br J Dermatol. 2021 Jun 25. doi: 10.1111/bjd.20597.
    >> Share

  75. PAPP KA, Lebwohl MG, Puig L, Ohtsuki M, et al
    Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.
    Br J Dermatol. 2021 Jun 22. doi: 10.1111/bjd.20595.
    >> Share

  76. PATHANIA YS
    Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations'.
    Br J Dermatol. 2021 Jun 22. doi: 10.1111/bjd.20590.
    >> Share

  77. SUGAYA M
    Search for the best biologic for psoriasis.
    Br J Dermatol. 2021 Jun 17. doi: 10.1111/bjd.20514.
    >> Share

  78. BRODERICK C, Christian N, Apfelbacher C, Bosma AL, et al
    The BIOMarkers in Atopic Dermatitis and Psoriasis (BIOMAP) Glossary: developing a lingua franca to facilitate data harmonisation and cross-cohort analyses.
    Br J Dermatol. 2021 Jun 16. doi: 10.1111/bjd.20587.
    >> Share

  79. BEYLOT-BARRY M, Seneschal J, Tran D, Bachelez H, et al
    Characteristics of patients with PASI <10 psoriasis treated with biological agents: Results from the French PsoBioTeq cohort.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20585.
    >> Share

  80. KIRBY L, Gran S, Orekoya F, Owen C, et al
    Is urinary incontinence associated with vulval lichen sclerosus in females? A cross-sectional study.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20583.
    >> Share

  81. SKAYEM C, Beylot-Barry M, de Masson A, Dereure O, et al
    Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases.
    Br J Dermatol. 2021 Jun 15. doi: 10.1111/bjd.20580.
    >> Share

  82. ADAN F, Nelemans PJ, Kelleners-Smeets NWJ, Kessels JPHM, et al
    The additional diagnostic value of optical coherence tomography in clinically diagnosed basal cell carcinomas undergoing direct surgical excision.
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20579.
    >> Share

  83. ISKANDAR IYK, Lunt M, Thorneloe RJ, Cordingley L, et al
    Alcohol abuse associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study.
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20577.
    >> Share

  84. SILVERBERG JI
    Association of atopic dermatitis and autoimmune comorbidities: is it real?
    Br J Dermatol. 2021 Jun 14. doi: 10.1111/bjd.20497.
    >> Share

  85. WIGGINS J, Polsky D
    Melanoma origins: data from early-stage tumours supports de novo and naevus-associated melanomas as distinct subtypes.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20396.
    >> Share

  86. EVERS AWM, van Beugen S
    How stress affects the skin: from designs to mechanisms.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20397.
    >> Share

  87. JOHANSSON EK
    Psychiatric conditions in children with atopic dermatitis.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20394.
    >> Share

  88. LINDER M
    Using epidemiological methods to quantify the risk of serious infections in children with atopic dermatitis.
    Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20395.
    >> Share

  89. AHMADY S, Oyen EMM, Jansen MHE, Nelemans PJ, et al
    Patient-reported skin reactions of 5% 5-fluorouracil in treatment of actinic keratosis.
    Br J Dermatol. 2021 Jun 10. doi: 10.1111/bjd.20570.
    >> Share

  90. GUILLAUME T, Puzenat E, Popescu D, Aubin F, et al
    Cemiplimab-rwlc in Advanced Cutaneous Squamous Cell Carcinoma: a real-life experience in a French Dermatology Department.
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20569.
    >> Share

  91. REICH K, Gordon KB, Strober BE, Armstrong AW, et al
    Five-year maintenance of clinical response and improvements in health-related quality of life in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2.
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20568.
    >> Share

  92. JOSHI TP, Ren V
    Response to "Evaluating World Health Organization Essential Medicines List for Skin Disease".
    Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20565.
    >> Share

  93. GUHAN S, Klebanov N, Tsao H
    Melanoma genomics: a state-of-the-art review of practical clinical applications.
    Br J Dermatol. 2021 Jun 6. doi: 10.1111/bjd.20421.
    >> Share

  94. BRUNNER PM, Conrad C, Vender R, Grond S, et al
    Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab.
    Br J Dermatol. 2021 Jun 2. doi: 10.1111/bjd.20527.
    >> Share

  95. WELSH E, Cardenas-de la Garza JA, Cuellar-Barboza A, Franco-Marquez R, et al
    SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
    Br J Dermatol. 2021;184:1194-1195.
    >> Share

  96. BERNIGAUD C, Guillemot D, Ahmed-Belkacem A, Grimaldi-Bensouda L, et al
    Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality.
    Br J Dermatol. 2021;184:1207-1209.
    >> Share


  97. Measuring the success of treatments for squamous cell cancer of the skin.
    Br J Dermatol. 2021;184:e196-e223.
    >> Share

  98. HASHIMOTO T
    Pathogenic role of ST18 in pemphigus vulgaris.
    Br J Dermatol. 2021;184:1001-1002.
    >> Share

  99. GUCKIAN J, Rajan N, Kibbi N
    Incompletely excised keratinocyte carcinomas: more common than once thought?
    Br J Dermatol. 2021;184:991.
    >> Share

  100. COTTER C, Kretz M, Rajan N
    Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage in vitiligo.
    Br J Dermatol. 2021;184:999-1000.
    >> Share

  101. BLOME C, Klein TM
    Classifying the severity of bullous pemphigoid disease.
    Br J Dermatol. 2021;184:997-998.
    >> Share

  102. ZOUBOULIS CC
    Pain Index: a new prospective hidradenitis suppurativa patient-reported outcome measure instrument.
    Br J Dermatol. 2021;184:1203-1204.
    >> Share

  103. BUONOMO M, Mansh MD, Thorpe D, Goldfarb N, et al
    Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy.
    Br J Dermatol. 2021;184:1192-1194.
    >> Share

  104. GUPTA R, Simonette RA, Doan HQ, Rady PL, et al
    Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment.
    Br J Dermatol. 2021;184:1185-1187.
    >> Share

  105. SCHMUTH M, Reichelt J, Gruber R
    Advancing novel therapies for ichthyoses.
    Br J Dermatol. 2021;184:998-999.
    >> Share

  106. GAO JM, Garioch JJ, Fadhil M, Tan E, et al
    Planning slow Mohs excision margins for lentigo maligna: a retrospective nonrandomized cohort study comparing reflectance confocal microscopy margin mapping vs. visual inspection with dermoscopy.
    Br J Dermatol. 2021;184:1182-1183.
    >> Share

  107. SMITH J, Ezekwe N, Pourang A, Hamzavi I, et al
    Multifocal myositis and elevated creatine phosphokinase associated with the use of ustekinumab for hidradenitis suppurativa.
    Br J Dermatol. 2021;184:1181-1182.
    >> Share

  108. GRAIER T, Salmhofer W, Jonak C, Weger W, et al
    Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
    Br J Dermatol. 2021;184:1094-1105.
    >> Share

  109. FELDMAN SR, Huang WW
    Evidence is lacking for or against palmoplantar pustulosis treatments: what does this mean for the clinician.
    Br J Dermatol. 2021;184:990.
    >> Share

  110. CHACKO AM, Lagace F, Jafarian F
    Ultraviolet index and sun safety: are we all on the same page?
    Br J Dermatol. 2021;184:1175-1176.
    >> Share

  111. ASSAF S, Malki L, Mayer T, Mohamad J, et al
    ST18 affects cell-cell adhesion in pemphigus vulgaris in a tumour necrosis factor-alpha-dependent fashion.
    Br J Dermatol. 2021;184:1153-1160.
    >> Share

  112. MASMOUDI W, Vaillant M, Vassileva S, Patsatsi A, et al
    International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
    Br J Dermatol. 2021;184:1106-1112.
    >> Share

  113. LI D, Ryu E, Saeidian AH, Youssefian L, et al
    GGCX mutations in a patient with overlapping pseudoxanthoma elasticum/cutis laxa-like phenotype.
    Br J Dermatol. 2021;184:1170-1174.
    >> Share

  114. WAN B, Ganier C, Du-Harpur X, Harun N, et al
    Applications and future directions for optical coherence tomography in dermatology.
    Br J Dermatol. 2021;184:1014-1022.
    >> Share

  115. OBEID G, Do G, Kirby L, Hughes C, et al
    Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments.
    Br J Dermatol. 2021;184:1023-1032.
    >> Share

  116. NARLA S, Azzam M, Townsend S, Vellaichamy G, et al
    Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils.
    Br J Dermatol. 2021;184:1004-1013.
    >> Share

  117. EBENS CL, McGrath JA, Riedl JA, Keith AR, et al
    Immune tolerance of allogeneic haematopoietic cell transplantation supports donor epidermal grafting of recessive dystrophic epidermolysis bullosa chronic wounds.
    Br J Dermatol. 2021;184:1161-1169.
    >> Share

    May 2021
  118. YEH I, Bastian BC
    Melanoma pathology: new approaches and classification.
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20427.
    >> Share

  119. VENABLES ZC
    Icelandic study of cutaneous squamous cell carcinoma (cSCC) epidemiology highlights the worldwide burden of disease and challenges of in situ and invasive cSCC registry data.
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20422.
    >> Share

  120. TAIEB A, Katoh N
    Regional differences between Japan and the Netherlands in atopic dermatitis patient-reported outcome measures: which interpretation?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20424.
    >> Share

  121. MAHAMAT-SALEH Y
    Is consumption of citrus associated with a higher risk of melanoma?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20408.
    >> Share

  122. VESTERGAARD C
    How clinical phenotypes can translate into taxonomy: can we judge atopic dermatitis by its cover?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20434.
    >> Share

  123. GALLON R, Kibbi N, Cook S, Santibanez-Koref M, et al
    Sebaceous tumours: A prototypical class of skin tumour for universal germline genetic testing.
    Br J Dermatol. 2021 May 29. doi: 10.1111/bjd.20522.
    >> Share

  124. NASR I, McGrath EJ, Harwood CA, Botting J, et al
    British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021.
    Br J Dermatol. 2021 May 29. doi: 10.1111/bjd.20524.
    >> Share

  125. YU W, Barrett J, Liu P, Parameswaran A, et al
    Novel Evidence of Androgen Receptor Immunoreactivity in Skin Tunnels of Hidradenitis Suppurativa: Assessment of Gender and Individual Variability.
    Br J Dermatol. 2021 May 28. doi: 10.1111/bjd.20520.
    >> Share

  126. LWIN SM, Snowden JA, Griffiths CEM
    The Promise and Challenges of Cell Therapy for Psoriasis.
    Br J Dermatol. 2021 May 26. doi: 10.1111/bjd.20517.
    >> Share

  127. RAZMI T M, Afra TP, Mohammed TP, Ashik PTM, et al
    COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations.
    Br J Dermatol. 2021 May 25. doi: 10.1111/bjd.20425.
    >> Share

  128. JONAK C, Alkon N, Rindler K, Rojahn TB, et al
    Single-cell RNAseq profiling in a patient with discordant primary cutaneous B and T cell lymphoma reveals micromilieu-driven immune skewing.
    Br J Dermatol. 2021 May 21. doi: 10.1111/bjd.20512.
    >> Share

  129. ROSELEUR J, Gonzalez-Chica DA, Emery J, Stocks NP, et al
    Skin checks and skin cancer diagnosis in Australian general practice before and during the COVID pandemic, 2011-2020.
    Br J Dermatol. 2021 May 19. doi: 10.1111/bjd.20494.
    >> Share

  130. KHURANA A, Mittal A, Jain R, Mishra A, et al
    Rarity of cutaneous findings among asymptomatic to mildly symptomatic COVID-19 patients admitted to a COVID Care facility in Delhi, India: An observational study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20488.
    >> Share

  131. QUEIROS C, Silva L, Miroux Catarino A, Labareda J, et al
    Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study.
    Br J Dermatol. 2021 May 16. doi: 10.1111/bjd.20487.
    >> Share

  132. THACI D, Eyerich K, Pinter A, Sebastian M, et al
    Direct Comparison of Risankizumab and Fumaric Acid Esters in Systemic-Therapy-Naive Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20481.
    >> Share

  133. DALAL G, Wright SJ, Vass CM, Davison NJ, et al
    Patient preferences for stratified medicine in psoriasis: a discrete choice experiment.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20482.
    >> Share

  134. GRETHER-BECK S, Felsner I, Brenden H, Marini A, et al
    Air pollution-induced tanning of human skin.
    Br J Dermatol. 2021 May 15. doi: 10.1111/bjd.20483.
    >> Share

  135. CLAESON M, Baade P, Marchetti M, Brown S, et al
    Comparative performance of predictors of death from thin (
    Br J Dermatol. 2021 May 12. doi: 10.1111/bjd.20480.
    >> Share

  136. VAZQUEZ T, Feng R, Williams KJ, Werth VP, et al
    Immunological and clinical heterogeneity in cutaneous lupus erythematosus.

    Br J Dermatol. 2021 May 9. doi: 10.1111/bjd.20085.
    >> Share

  137. SANGERS TE, Wakkee M, Kramer-Noels EC, Nijsten T, et al
    Views on Mobile Health Apps for Skin Cancer Screening in the General Population: An In-Depth Qualitative Exploration of Perceived Barriers and Facilitators.
    Br J Dermatol. 2021 May 7. doi: 10.1111/bjd.20441.
    >> Share

  138. GAUNT N, Green RL, Motta LF, Jamieson LA, et al
    Skin cancers in lockdown: no impact on pathological tumour staging.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20438.
    >> Share

  139. FLEDDERUS AC, Pasmans SGMA, Wolkerstorfer A, Oei W, et al
    Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research, part 2 (the OCOMEN project).
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20437.
    >> Share

  140. CHEN Y, Andre M, Adhikari K, Blin M, et al
    A GWAS identifies novel gene associations with facial skin wrinkling and mole count in Latin-Americans.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20436.
    >> Share

  141. NGUYEN C, Yale K, Casale F, Ghigi A, et al
    SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.
    Br J Dermatol. 2021 May 6. doi: 10.1111/bjd.20435.
    >> Share

  142. BECHER G, Burden AD
    Psoriasis, COVID-19 and shielding.
    Br J Dermatol. 2021 May 5. doi: 10.1111/bjd.20055.
    >> Share

  143. SCHNUCH A
    Hand eczema in young people: atopic dermatitis and beyond.
    Br J Dermatol. 2021 May 4. doi: 10.1111/bjd.20142.
    >> Share

  144. ZIMMERMANN C, Boisson M, Ram-Wolff C, Sadoux A, et al
    Diagnostic performance of high throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma.
    Br J Dermatol. 2021 May 3. doi: 10.1111/bjd.20432.
    >> Share

  145. VENABLES ZC, Ahmed S, Bleiker T, Broggio J, et al
    The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020.
    Br J Dermatol. 2021 May 3. doi: 10.1111/bjd.20409.
    >> Share

  146. WOLKERSTORFER A
    Evidence for efficacy of home-based narrowband ultraviolet B therapy.
    Br J Dermatol. 2021;184:790.
    >> Share

  147. EMTESTAM L, Lapins J, Sartorius K
    A growing family of outcome measurement proposals for hidradenitis suppurativa.
    Br J Dermatol. 2021;184:796-798.
    >> Share

  148. HERISSE AL, Charlesworth A, Bellon N, Leclerc-Mercier S, et al
    Genotypic and phenotypic analysis of 34 cases of inherited junctional epidermolysis bullosa caused by COL17A1 mutations.
    Br J Dermatol. 2021;184:960-962.
    >> Share

  149. JERJEN R, Koh WL, Sinclair R, Bhoyrul B, et al
    Low-dose oral minoxidil improves global hair density and length in children with loose anagen hair syndrome.
    Br J Dermatol. 2021;184:977-978.
    >> Share

  150. ZOUBOULIS CC, Altenburg A
    Interleukin-18 is a sensitive marker of flare initiation in Adamantiades-Behcet disease.
    Br J Dermatol. 2021;184:973-975.
    >> Share

  151. ZIGLER CK, Roberts A
    A child's experience of itch: the first step towards patient-centred measures.
    Br J Dermatol. 2021;184:795-796.
    >> Share

  152. MOLLOY K, Vico C, Ortiz-Romero PL, Scarisbrick JJ, et al
    Real-world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2021;184:978-981.
    >> Share

  153. KRAIN RL, Bax CE, Chakka S, Ahmed S, et al
    Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area Index.
    Br J Dermatol. 2021;184:975-977.
    >> Share

  154. MARQUES E, Arenberger P, Smetanova A, Gkalpakiotis S, et al
    Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha.
    Br J Dermatol. 2021;184:966-967.
    >> Share

  155. ONOUFRIADIS A, Boulouadnine B, Dachy G, Higashino T, et al
    A germline mutation in the platelet-derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis.
    Br J Dermatol. 2021;184:967-970.
    >> Share

  156. BERTOLOTTI A, Sbidian E, Join-Lambert O, Bourgault-Villada I, et al
    Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
    Br J Dermatol. 2021;184:963-965.
    >> Share

  157. RICAR J, Cetkovska P
    Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab.
    Br J Dermatol. 2021;184:e148.
    >> Share

  158. BHANOT A, Peters TJ, Ridd MJ
    Assessing the validity, responsiveness and reliability of the Recap measure of eczema control.
    Br J Dermatol. 2021;184:955-957.
    >> Share

  159. BROWN SJ
    Translational genetics: a challenging but important path.
    Br J Dermatol. 2021;184:800-801.
    >> Share

  160. LEB-REICHL V, Guttmann-Gruber C, Pinon Hofbauer J
    Linked in: the extracellular matrix network in tumour dissemination.
    Br J Dermatol. 2021;184:799.
    >> Share

  161. COTTER C, Ferguson J
    'Ruxolitinib cream for the treatment of vitiligo: a randomised, controlled, phase 2 trial': a critical appraisal.
    Br J Dermatol. 2021;184:826-827.
    >> Share

  162. SIBBALD C
    Long-term safety of dupilumab in children.
    Br J Dermatol. 2021;184:792-793.
    >> Share

  163. ROGERS A, Akram P, Batchelor JM, Crutchley J, et al
    Quality assurance and characterization of narrowband ultraviolet B devices for use at home: lessons from the HI-Light Vitiligo Trial.
    Br J Dermatol. 2021;184:954-955.
    >> Share

  164. ASCOTT A, Mansfield KE, Schonmann Y, Mulick A, et al
    Atopic eczema and obesity: a population-based study.
    Br J Dermatol. 2021;184:871-879.
    >> Share

  165. THOMAS KS, Batchelor JM, Akram P, Chalmers JR, et al
    Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Br J Dermatol. 2021;184:828-839.
    >> Share

  166. GOLDFARB N, Lowes MA, Butt M, King T, et al
    Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
    Br J Dermatol. 2021;184:905-912.
    >> Share

  167. SACH TH, Thomas KS, Batchelor JM, Perways A, et al
    An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
    Br J Dermatol. 2021;184:840-848.
    >> Share

  168. PAPANIKOLAOU M, Onoufriadis A, Mellerio JE, Nattkemper LA, et al
    Prevalence, pathophysiology and management of itch in epidermolysis bullosa.
    Br J Dermatol. 2021;184:816-825.
    >> Share

  169. ONOUFRIADIS A, Cabezas A, Ng JCF, Canales J, et al
    Autosomal recessive hypotrichosis with loose anagen hairs associated with TKFC mutations.
    Br J Dermatol. 2021;184:935-943.
    >> Share

  170. LOUSADA MB, Lachnit T, Edelkamp J, Rouille T, et al
    Exploring the human hair follicle microbiome.
    Br J Dermatol. 2021;184:802-815.
    >> Share

    April 2021
  171. IZNARDO H, Vilarrasa E, Lopez-Ferrer A, Puig L, et al
    Real world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20416.
    >> Share

  172. GOTTLIEB AB, Merola JF, Reich K, Behrens F, et al
    Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with concomitant moderate to severe plaque psoriasis: Results from the EXCEED, a randomised, double-blind head-to-head monotherapy study.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20413.
    >> Share

  173. MORENO-ARRONES OM, Ortega-Quijano D, Perez-Brocal V, Fernandez-Nieto D, et al
    Dysbiotic gut microbiota in inflammatory rosacea patients: another clue towards the existence of a brain-gut-skin axis.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20411.
    >> Share

  174. CHAN AA, Noguti J, Yang CT, Feldman SR, et al
    Association between Menopausal Hormone Therapy and Incidence of Psoriasis: A Secondary Analysis from the Women's Health Initiative Randomized Clinical Trials.
    Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20410.
    >> Share

  175. PENSO L, Dray-Spira R, Weill A, Zureik M, et al
    Drop in biological initiation for patients with psoriasis during the COVID-pandemic.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20406.
    >> Share

  176. DOUSSET L, Martins C, Jacquemin C, Amico S, et al
    Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with high frequency of melanoma-infiltrating CXCR3(+) resident memory CD8(+) T cells and multiple chemokine pathways.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20405.
    >> Share

  177. SUTARIA N, Parthasarathy V, Roh YS, Choi J, et al
    Itch in Skin of Color: A multicenter cross-sectional study.
    Br J Dermatol. 2021 Apr 24. doi: 10.1111/bjd.20403.
    >> Share

  178. JI-XU A, Lei DK, Nguyen KA, Yang JJ, et al
    The Burden of Immune-Mediated Skin Disease in HIV/AIDS Inpatients.
    Br J Dermatol. 2021 Apr 22. doi: 10.1111/bjd.20401.
    >> Share

  179. DESSINIOTI C, Geller AC, Whiteman DC, Garbe C, et al
    Not all melanomas are created equal: A review and call for more research into nodular melanoma.
    Br J Dermatol. 2021 Apr 16. doi: 10.1111/bjd.20388.
    >> Share

  180. RAIKER R, Pakhchanian H, Hussain A, Deng M, et al
    Outcomes of COVID-19 in Patients with Skin Cancer.
    Br J Dermatol. 2021 Apr 10. doi: 10.1111/bjd.20386.
    >> Share

  181. MAUL JT, Augustin M, Sorbe C, Conrad C, et al
    Association of gender and systemic therapy treatment outcomes in psoriasis: a two-country, multi-centre, prospective, non-interventional registry study.
    Br J Dermatol. 2021 Apr 10. doi: 10.1111/bjd.20387.
    >> Share

  182. LEBWOHL M, Deodhar A, Griffiths CEM, Menter MA, et al
    The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data.
    Br J Dermatol. 2021 Apr 8. doi: 10.1111/bjd.20136.
    >> Share

  183. CHAN WH, Srivastava R, Damaraju N, Do H, et al
    Automated detection of skin reactions in epicutaneous patch testing using machine learning.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20141.
    >> Share

  184. GEIFMAN N, Azadbakht N, Zeng J, Wilkinson T, et al
    Defining Trajectories of Response in Psoriasis Patients Treated with Biologic Therapies.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20140.
    >> Share

  185. YKEMA BLM, Adan F, Crijns MB, Bleeker FE, et al
    Cutaneous squamous cell carcinoma is associated with Lynch syndrome; widening the spectrum of Lynch syndrome associated tumours.
    Br J Dermatol. 2021 Apr 7. doi: 10.1111/bjd.20139.
    >> Share

  186. VAN DELFT LCJ, Kelleners-Smeets NWJ
    Interventions for basal cell carcinoma: from evidence to personalized treatment.
    Br J Dermatol. 2021 Apr 6. doi: 10.1111/bjd.20059.
    >> Share

  187. KITTLER H
    Total body photography for secondary prevention of melanoma.
    Br J Dermatol. 2021 Apr 6. doi: 10.1111/bjd.20058.
    >> Share

  188. BAURECHT H, Welker C, Baumeister SE, Weidnger S, et al
    Relationship between Atopic Dermatitis, Depression and Anxiety: a two-sample Mendelian randomization study.
    Br J Dermatol. 2021 Apr 4. doi: 10.1111/bjd.20092.
    >> Share

  189. JENDOUBI F, Shourick J, Negretto M, Laurent C, et al
    Cutaneous mastocytosis in adult patients with serum tryptase level under 20 ng/ml: why we should investigate further.
    Br J Dermatol. 2021 Apr 3. doi: 10.1111/bjd.20098.
    >> Share

  190. CARVALHO AF, Machado MO, Mallia E, Liu X, et al
    The Association Between Schizophrenia Spectrum Disorders and Psoriasis: a large-scale population-based case-control study.
    Br J Dermatol. 2021 Apr 2. doi: 10.1111/bjd.20094.
    >> Share

  191. ABO-TABIK M, Parisi R, Willis SC, Griffiths CEM, et al
    Development of clinical diagnostic criteria for chronic plaque psoriasis: an international e-Delphi study.
    Br J Dermatol. 2021 Apr 2. doi: 10.1111/bjd.20096.
    >> Share

  192. SCHMITT T, Egu DT, Walter E, Sigmund AM, et al
    Ca(2+) signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus.
    Br J Dermatol. 2021 Apr 1. doi: 10.1111/bjd.20091.
    >> Share

  193. TOLLENAERE MAX, Hebsgaard J, Ewald DA, Lovato P, et al
    Signaling of multiple IL-17 family cytokines through IL-17RA drive psoriasis-related inflammatory pathways.
    Br J Dermatol. 2021 Apr 1. doi: 10.1111/bjd.20090.
    >> Share


  194. What is the best surgical treatment for dermatofibrosarcoma protuberans?
    Br J Dermatol. 2021;184:e126-e147.
    >> Share

  195. PORCU P, Nikbakht N
    New insights on treatment utilization and outcomes in early-stage mycosis fungoides.
    Br J Dermatol. 2021;184:594-595.
    >> Share

  196. VEERABAGU SA, Lauth MJ, Obayomi A, Correa M, et al
    Hair stylists as screeners for scarring hair loss within the African American community: a cross-sectional study.
    Br J Dermatol. 2021;184:769-770.
    >> Share

  197. MACHADO MO, Lu JD, Brar R, Kirby JS, et al
    Hidradenitis suppurativa odour and drainage scale: a novel method for evaluating odour and drainage in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:772-774.
    >> Share

  198. FROMMHERZ LH, Schempp CM, Has C
    Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency.
    Br J Dermatol. 2021;184:770-772.
    >> Share

  199. ZHANG J, Qin W, Hua S, Li M, et al
    Cafe au lait macules overlying segmental macular hyperpigmentation in a paediatric patient: an early sign for mosaic neurofibromatosis type 1.
    Br J Dermatol. 2021;184:742-743.
    >> Share

  200. GUTTMANN-GRUBER C, Pinon Hofbauer J
    Transforming growth factor-beta messaging: #ContextMatters.
    Br J Dermatol. 2021;184:592-593.
    >> Share

  201. BRUINSMA RL, Fajgenbaum K, Yang Y, Del Mar Melendez-Gonzalez M, et al
    Assessment of familial risk in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:753-754.
    >> Share

  202. VAN DEN BOS RR
    Dermatofibrosarcoma protuberans: slowly gathering evidence for optimal treatment of a slow-growing tumour.
    Br J Dermatol. 2021;184:595.
    >> Share

  203. AGRAWAL R, Tso S, Eltigani EA, Busam KJ, et al
    PRAME immunohistochemistry as an adjunct in the diagnosis of paucicellular lentigo maligna in a young man.
    Br J Dermatol. 2021;184:e122.
    >> Share

  204. AMRANI A, Das A
    Cydnidae pigmentation: unusual location on the abdomen and back.
    Br J Dermatol. 2021;184:e125.
    >> Share

  205. BONIFAZ A, Fernandez-Samar D, Tirado-Sanchez A, Vazquez-Gonzalez D, et al
    Hidradenitis suppurativa associated with actinomycosis owing to Actinomyces meyeri.
    Br J Dermatol. 2021;184:e123-e124.
    >> Share

  206. OH J, Lee RW, Lee HR, Lee SB, et al
    Classification of facial and truncal segmental vitiligo and its clinical courses including recurrence rate and patterns: a retrospective review of 956 patients.
    Br J Dermatol. 2021;184:750-753.
    >> Share

  207. ZOUBOULIS CC, Readhead B, Dudley JT
    An additional drug repurposing study for hidradenitis suppurativa/acne inversa.
    Br J Dermatol. 2021;184:748-750.
    >> Share

  208. CAPOZZA K
    Never the twain shall meet? Bridging the divide between patient perspectives and health professionals and systems.
    Br J Dermatol. 2021;184:587-588.
    >> Share

  209. ELEFTHERIADOU V
    Outcomes for Pressure Ulcer Trials (OUTPUTs) project: first key step on a long journey.
    Br J Dermatol. 2021;184:587.
    >> Share

  210. WORTSMAN X
    Strong validation of ultrasound as an imaging biomarker in hidradenitis suppurativa.
    Br J Dermatol. 2021;184:591-592.
    >> Share

  211. GRAND D, Frew JW, Navrazhina K, Krueger JG, et al
    Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.
    Br J Dermatol. 2021;184:688-696.
    >> Share

  212. KIRBY JS, Hereford B, Thorlacius L, Villumsen B, et al
    Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:681-687.
    >> Share

  213. DURACK A, Gran S, Gardiner MD, Jain A, et al
    A 10-year review of surgical management of dermatofibrosarcoma protuberans.
    Br J Dermatol. 2021;184:731-739.
    >> Share

  214. TEASDALE E, Muller I, Sivyer K, Ghio D, et al
    Views and experiences of managing eczema: systematic review and thematic synthesis of qualitative studies.
    Br J Dermatol. 2021;184:627-637.
    >> Share

  215. LECHNER A, Kottner J, Coleman S, Muir D, et al
    Outcomes for Pressure Ulcer Trials (OUTPUTs) project: review and classification of outcomes reported in pressure ulcer prevention research.
    Br J Dermatol. 2021;184:617-626.
    >> Share

    March 2021
  216. MARLEY AR, Li M, Champion VL, Song Y, et al
    The Association between Citrus Consumption and Melanoma Risk in the UK Biobank.
    Br J Dermatol. 2021 Mar 30. doi: 10.1111/bjd.19896.
    >> Share

  217. GHIASVAND R
    Divergent pathways for melanoma: what is the role of genetics?
    Br J Dermatol. 2021 Mar 25. doi: 10.1111/bjd.19887.
    >> Share

  218. RUNDLE CW, Fortugno AP, Maghfour J, Presley CL, et al
    Evaluating World Health Organization Essential Medicines List for Skin Disease.
    Br J Dermatol. 2021 Mar 25. doi: 10.1111/bjd.20081.
    >> Share

  219. VAN VOORHEES AS, Stein Gold L, Lebwohl M, Strober B, et al
    Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: results up to 32 weeks from a randomised, phase 3 study.
    Br J Dermatol. 2021 Mar 24. doi: 10.1111/bjd.20083.
    >> Share

  220. PARK S, Ha KH, Kim TG, Kim HC, et al
    Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea.
    Br J Dermatol. 2021 Mar 24. doi: 10.1111/bjd.20079.
    >> Share

  221. O'SHAUGHNESSY RFL
    Ceramide kinase-like protein, 'the kinase that isn't', finds a role in skin cancer stress relief.
    Br J Dermatol. 2021 Mar 23. doi: 10.1111/bjd.19888.
    >> Share

  222. HEPPT MV, Steeb T, Berking C
    One set to collect them all? The development of a core domain set for medium-to-giant congenital melanocytic naevi.
    Br J Dermatol. 2021 Mar 23. doi: 10.1111/bjd.19878.
    >> Share

  223. SHAH P, Svigos K, Yin L, Soter N, et al
    Differences in the Clinical Presentation of Bullous Pemphigoid in Skin of Color and White Patients.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20068.
    >> Share

  224. SILVERBERG JI, Lai JS, Cella D
    Reliability and meaningful change of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire(R) (PIQ) Item-Banks in adults with atopic dermatitis.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20066.
    >> Share

  225. TSAI TF
    Secukinumab 2-weekly vs. 4-weekly dosing in plaque-type psoriasis.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.19570.
    >> Share

  226. MOITINHO-SILVA L, Boraczynski N, Emmert H, Baurecht H, et al
    Host traits, lifestyle and environment are associated with the human skin bacteria.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20072.
    >> Share

  227. THOMPSON LL, Li EB, Krasnow NA, Chang MS, et al
    Effect of Dermatologic Consultation on Survival in Patients with Checkpoint Inhibitor Associated Cutaneous Toxicity.
    Br J Dermatol. 2021 Mar 18. doi: 10.1111/bjd.20074.
    >> Share

  228. YIU ZZN, Harding G, Griffiths CEM, Warren RB, et al
    Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single centre, cross-sectional study.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20062.
    >> Share

  229. MIRZA FN, Wang A, Ramachandran SM, Damsky W, et al
    Dupilumab induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo IL-17A expression: a case report.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20064.
    >> Share

  230. RAMIEN ML, Bahubeshi A, Lara-Corrales I, Pope E, et al
    Blistering severe cutaneous adverse reactions in children: Proposal for pediatric-focused clinical criteria.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20063.
    >> Share

  231. SCHONMANN Y, Mansfield KE, Mulick A, Roberts A, et al
    Inflammatory Skin Diseases and the Risk of Chronic Kidney Disease - Population-Based Case-control and Cohort analyses.
    Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20067.
    >> Share

  232. OKOJI UK, Taylor SC, Lipoff JB
    Equity in skin typing: why it's time to replace the Fitzpatrick scale.
    Br J Dermatol. 2021 Mar 5. doi: 10.1111/bjd.19932.
    >> Share

  233. NALDI L
    The skin as a target for SARS-CoV-2 infection: exploiting the web for suitable data.
    Br J Dermatol. 2021 Mar 4. doi: 10.1111/bjd.19877.
    >> Share

  234. PEREZ M, Chakraborty A, Lau LS, Mohammed NBB, et al
    Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19891.
    >> Share

  235. BRUGGEN MC, Le ST, Walsh S, Toussi A, et al
    Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19893.
    >> Share

  236. DE WIJS LEM, Fujimoto RFT, Andrinopoulou ER, Nijsten TEC, et al
    Dupilumab treatment in atopic dermatitis patients in the Netherlands versus Japan: a comparative cohort study revealing a discrepancy in patient-reported outcome measures.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19897.
    >> Share

  237. MORRISON PJ, Suhrkamp I, Gerdes S, Mrowietz U, et al
    Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of psoriasis patients that are linked with skin improvement.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19899.
    >> Share

  238. EL SHAROUNI MA, Varey AHR, Witkamp AJ, Ahmed T, et al
    Predicting sentinel node positivity in melanoma patients: external validation of a risk-prediction calculator (the MIA nomogram) using a large European population-based patient cohort.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19895.
    >> Share

  239. VERMEER M
    Epidemiology of cutaneous lymphoma.
    Br J Dermatol. 2021 Mar 3. doi: 10.1111/bjd.19829.
    >> Share

  240. MULICK AR, Mansfield KE, Silverwood RJ, Buddu-Aggrey A, et al
    Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort.
    Br J Dermatol. 2021 Mar 2. doi: 10.1111/bjd.19885.
    >> Share

  241. LEITER U
    What is new in the 2020 British guidelines for cutaneous squamous cell carcinoma?
    Br J Dermatol. 2021;184:384-385.
    >> Share

  242. HUGO J, Arenbergerova M, Arenberger P, Gkalpakiotis S, et al
    Coexistence of palmoplantar pustulosis and ichthyosis vulgaris treated by risankizumab.
    Br J Dermatol. 2021 Mar 1. doi: 10.1111/bjd.19835.
    >> Share

  243. O'NEILL H, Narang I, Buckley DA, Phillips TA, et al
    Occupational dermatoses during the COVID-19 pandemic: a multicentre audit in the UK and Ireland.
    Br J Dermatol. 2021;184:575-577.
    >> Share

  244. BOUAZZI D, McPhie ML, Kjaersgaard Andersen R, Alavi A, et al
    Hidradenitis suppurativa and perceived stigmatization in a diverse Canadian clinic population: a pilot study.
    Br J Dermatol. 2021;184:570-571.
    >> Share

  245. BAX CE, Ravishankar A, Yan D, Concha J, et al
    Identifying the required degree of disease clearance to improve quality of life in pemphigus vulgaris.
    Br J Dermatol. 2021;184:573-575.
    >> Share

  246. MA Y, Zhao C, Li R, Wang X, et al
    Actinomycetoma caused by Nocardia asiatica associated with traditional Chinese medicine foot bath.
    Br J Dermatol. 2021;184:e55.
    >> Share

  247. HADDAD N, Delyon J, Trabelsi Messai S, Herms F, et al
    Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy.
    Br J Dermatol. 2021;184:564-566.
    >> Share

  248. DE VERE HUNT I, McNiven A, McPherson T
    A qualitative exploration of the experiences of adolescents with alopecia areata and their messages for healthcare professionals.
    Br J Dermatol. 2021;184:557-559.
    >> Share

  249. LU JD, Milakovic M, Piguet V, Alavi A, et al
    Antidrug antibodies to tumour necrosis factor inhibitors in hidradenitis suppurativa: a systematic review.
    Br J Dermatol. 2021;184:555-557.
    >> Share

  250. YAO Y, Jorgensen AR, Ring HC, Thomsen SF, et al
    Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study.
    Br J Dermatol. 2021;184:552-553.
    >> Share

  251. MORENO ARTERO E, Schinkel N, Chaumon S, Corset I, et al
    Efficacy of topical ropivacaine in children and young adults with hereditary epidermolysis bullosa.
    Br J Dermatol. 2021;184:550-552.
    >> Share

  252. JIYAD Z, Marquart L, Green AC
    A call to standardize the BCC:SCC ratio.
    Br J Dermatol. 2021;184:545.
    >> Share

  253. PARARAJASINGAM A, Atwan A, Srivastava P, Chowdhury MMU, et al
    Shades of grey: an outbreak of tattoo-associated Mycobacterium chelonae.
    Br J Dermatol. 2021;184:e54.
    >> Share

  254. HODAK E, Sherman S, Papadavid E, Bagot M, et al
    Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
    Br J Dermatol. 2021;184:524-531.
    >> Share

  255. GABES M, Jourdan C, Schramm K, Masur C, et al
    Hyperhidrosis Quality of Life Index (HidroQoL(c)): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial.
    Br J Dermatol. 2021;184:473-481.
    >> Share

  256. BODEMER C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA, et al
    Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.
    Br J Dermatol. 2021;184:393-400.
    >> Share

    February 2021
  257. KOGAME T, Kambe N, Takimoto-Ito R, Nomura T, et al
    Skin-associated lymphoid tissue could be a sign of systemic disease: reply from authors.
    Br J Dermatol. 2021 Feb 22. doi: 10.1111/bjd.19884.
    >> Share

  258. WANG C
    Skin-associated lymphoid tissue could be a sign of systemic disease.
    Br J Dermatol. 2021 Feb 21. doi: 10.1111/bjd.19881.
    >> Share

  259. SCHNEIDER R, Reinau D, Stoffel S, Jick SS, et al
    Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19880.
    >> Share

  260. ADALSTEINSSON JA, Olafsdottir E, Ratner D, Waldman R, et al
    Invasive and In-Situ Squamous Cell Carcinoma of the Skin: A Nationwide Study in Iceland.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19879.
    >> Share

  261. SOTIRIOU E, Bakirtzi K, Papadimitriou I, Paschou E, et al
    Intention of COVID-19 vaccination among psoriatic patients compared to immunosuppressed patients with other skin diseases and factors influencing their decision.
    Br J Dermatol. 2021 Feb 20. doi: 10.1111/bjd.19882.
    >> Share

  262. PILKINGTON SM
    The importance of keratinocyte-dendritic cell interactions in understanding fragrance allergy.
    Br J Dermatol. 2021 Feb 18. doi: 10.1111/bjd.19828.
    >> Share

  263. ABUABARA K, Nicholls SG, Langan SM, Guttman-Yassky E, et al
    Priority research questions in atopic dermatitis: An International Eczema Council eDelphi consensus.
    Br J Dermatol. 2021 Feb 11. doi: 10.1111/bjd.19874.
    >> Share

  264. HODGES WT, Bhat T, Raval NS, Herbosa C, et al
    Biologics utilization for psoriasis is lower in Black compared to Caucasian patients.
    Br J Dermatol. 2021 Feb 10. doi: 10.1111/bjd.19876.
    >> Share

  265. OMODAKA T, Minagawa A, Okuyama R
    Ultraviolet-related skin cancers distribute differently on the face surface.
    Br J Dermatol. 2021 Feb 10. doi: 10.1111/bjd.19875.
    >> Share

  266. VERMEER HAB, Rashid H, Esajas MD, Oldhoff JM, et al
    The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina.
    Br J Dermatol. 2021 Feb 6. doi: 10.1111/bjd.19870.
    >> Share

  267. TAYLOR MT, Noe MH, Horton DB, Barbieri JS, et al
    Trends in opioid prescribing at outpatient visits for psoriasis and psoriatic arthritis.
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19865.
    >> Share

  268. WOLNER ZJ, Flowers NI, Yushak ML, Chen SC, et al
    Exploring the melanoma survivorship experience: a qualitative study.
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19868.
    >> Share

  269. THACI D, Piaserico S, Warren RB, Gupta AK, et al
    Five-year efficacy and safety of tildrakizumab in patients with moderate to severe psoriasis who respond at week 28: pooled analyses of two randomised phase 3 clinical trials (reSURFACE 1 and reSURFACE 2).
    Br J Dermatol. 2021 Feb 5. doi: 10.1111/bjd.19866.
    >> Share

  270. NAPOLITANO M, Caiazzo G, Fabbrocini G, Balato A, et al
    Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment.
    Br J Dermatol. 2021;184:341-343.
    >> Share

  271. WINGE MCG, Iberri DJ, Novoa RA, Kwong BY, et al
    Telescope punch biopsy of normal-appearing skin to diagnose intravascular lymphoma.
    Br J Dermatol. 2021 Feb 1. doi: 10.1111/bjd.19711.
    >> Share

  272. LUCAS JA
    Using electronic health records to examine links between atopic dermatitis and obesity.
    Br J Dermatol. 2021 Feb 1. doi: 10.1111/bjd.19758.
    >> Share

  273. FLOHR C, Hay R
    Putting the burden of skin diseases on the global map.
    Br J Dermatol. 2021;184:189-190.
    >> Share


  274. Somatostatin receptors: an alternative treatment target for advanced Merkel cell carcinoma.
    Br J Dermatol. 2021;184:e32-e52.
    >> Share

  275. CUST AE
    A different finding on whether naevus numbers change during adulthood.
    Br J Dermatol. 2021;184:193.
    >> Share

  276. FREW JW, Navrazhina K, Sullivan-Whalen M, Gilleaudeau P, et al
    Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study.
    Br J Dermatol. 2021;184:350-352.
    >> Share

  277. GONCALO M, Gimenez-Arnau A, Al-Ahmad M, Ben-Shoshan M, et al
    The global burden of chronic urticaria for the patient and society.
    Br J Dermatol. 2021;184:226-236.
    >> Share

  278. LERTPHANICHKUL C, Smith GP
    Evaluation of malignancy risk in scleroderma by antibody profile.
    Br J Dermatol. 2021;184:369-371.
    >> Share

  279. GARCOVICH S, Tricarico PM, Meddour CN, Giovanardi G, et al
    Comorbid acne inversa and Dowling-Degos disease due to a single NCSTN mutation: is there enough evidence? Reply from the authors.
    Br J Dermatol. 2021;184:375-376.
    >> Share

  280. HERMASCH MA, Schon MP, Frank J
    Comorbid acne inversa and Dowling-Degos disease due to a single NCSTN mutation: is there enough evidence?
    Br J Dermatol. 2021;184:374.
    >> Share

  281. SAMIMI M, Becker J
    There is still a place for tumour-targeted therapies in Merkel cell carcinoma in the era of immune checkpoint inhibitors.
    Br J Dermatol. 2021;184:195-197.
    >> Share

  282. RAMELYTE E, Restivo G, Imhof L, Nageli MC, et al
    How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?
    Br J Dermatol. 2021;184:359-361.
    >> Share

  283. MIURA H, Takada M, Fujiwara M, Fujiwara S, et al
    Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma.
    Br J Dermatol. 2021;184:e30.
    >> Share

  284. LAYTON AM, Thiboutot D, Tan J
    Reviewing the global burden of acne: how could we improve care to reduce the burden?
    Br J Dermatol. 2021;184:219-225.
    >> Share

  285. ARDON CB, Wang C, Prens EP, van Straalen KR, et al
    Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches.
    Br J Dermatol. 2021;184:343-345.
    >> Share

  286. SALEVA-STATEVA M, Technau-Hafsi K, Frommherz L, Gruninger G, et al
    Recurrent MVD mutation in European patients with disseminated porokeratosis.
    Br J Dermatol. 2021;184:347-348.
    >> Share

  287. BARBIERI JS
    New oral antifungals for onychomycosis: interesting potential and the need for comparative effectiveness trials.
    Br J Dermatol. 2021;184:191.
    >> Share

  288. ELEWSKI B, Brand S, Degenhardt T, Curelop S, et al
    A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.
    Br J Dermatol. 2021;184:270-280.
    >> Share

  289. RIBERO S, Zugna D, Spector T, Bataille V, et al
    Natural history of naevi: a two-wave study.
    Br J Dermatol. 2021;184:289-295.
    >> Share

  290. COX V, Fuller LC, Engelman D, Steer A, et al
    Estimating the global burden of scabies: what else do we need?
    Br J Dermatol. 2021;184:237-242.
    >> Share

  291. LONEY T, Paulo MS, Modenese A, Gobba F, et al
    Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review.
    Br J Dermatol. 2021;184:208-218.
    >> Share

  292. AKAIKE T, Qazi J, Anderson A, Behnia FS, et al
    High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma.
    Br J Dermatol. 2021;184:319-327.
    >> Share

    January 2021
  293. ENDRE KMA, Landro L, LeBlanc M, Gjersvik P, et al
    Diagnosing Atopic Dermatitis in Infancy Using Established Diagnostic Criteria: A Cohort Study.
    Br J Dermatol. 2021 Jan 28. doi: 10.1111/bjd.19831.
    >> Share

  294. SHIIYA C, Aoki S, Nakabayashi K, Hata K, et al
    Linear and disseminated porokeratosis in one family showing identical and independent second hits in MVD among skin lesions, respectively: A proof of concept study.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19824.
    >> Share

  295. TASCILAR K, Bayindir O, Dogru A, Tinazzi I, et al
    Association of Disease Characteristics with the Temporal Sequence of Skin and Musculoskeletal Disease Onset in Psoriatic Arthritis.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19826.
    >> Share

  296. WEHKAMP U, Mitteldorf C, Stendel S, Stranzenbach R, et al
    Most rare subtypes of cutaneous lymphoma display variable CD30 expression. Analysis of the German Cutaneous Lymphoma Network.
    Br J Dermatol. 2021 Jan 22. doi: 10.1111/bjd.19823.
    >> Share

  297. DROITCOURT C, Vittrup I, Dupuy A, Egeberg A, et al
    The risk of systemic infections requiring hospitalisation in children with atopic dermatitis: a Danish retrospective nationwide cohort study.
    Br J Dermatol. 2021 Jan 21. doi: 10.1111/bjd.19825.
    >> Share

  298. DESSINIOTI C, Geller AC, Stergiopoulou A, Dimou N, et al
    A multicenter study of nevus-associated melanoma versus de novo melanoma, tumor thickness and body site differences.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19819.
    >> Share

  299. SILVERBERG JI, Warshaw EM, Maibach HI, DeKoven JG, et al
    Hand Eczema in Children Referred for Patch Testing: North American Contact Dermatitis Group Data, 2000-2016.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19818.
    >> Share

  300. VITTRUP I, Andersen YMF, Droitcourt C, Skov L, et al
    Association between hospital-diagnosed atopic dermatitis and psychiatric disorders and medication use in childhood.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19817.
    >> Share

  301. NAGORE E, Martinez-Garcia MA, Gomez-Olivas JD, Manrique-Silva E, et al
    Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: An observational multi-centric study in 443 patients with melanoma.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19813.
    >> Share

  302. HICKERSON RP, Conneely MJ, Tsutsumi SKH, Wood K, et al
    Minimal, superficial DNA damage in human skin from filtered far-ultraviolet-C (UV-C).
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19816.
    >> Share

  303. VORNWEG J, Glaser S, Ahmad-Anwar M, Zimmer AD, et al
    Identification of compound heterozygous mutations in AP1B1 leading to the newly-described recessive keratitis-ichthyosis-deafness (KIDAR) syndrome.
    Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19815.
    >> Share

  304. LESTER JC, Clark L Jr, Linos E, Daneshjou R, et al
    Clinical Photography in Skin of Color: Tips and Best Practices.
    Br J Dermatol. 2021 Jan 15. doi: 10.1111/bjd.19811.
    >> Share

  305. THOMSON J, Hogan S, Leonardi-Bee J, Williams HC, et al
    Interventions for basal cell carcinoma: abridged Cochrane systematic review and grade assessments.
    Br J Dermatol. 2021 Jan 15. doi: 10.1111/bjd.19809.
    >> Share

  306. VISCONTI A, Bataille V, Rossi N, Kluk J, et al
    Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection.
    Br J Dermatol. 2021 Jan 14. doi: 10.1111/bjd.19807.
    >> Share

  307. KAMIDO H, Shimomiya D, Kogame T, Takimoto-Ito R, et al
    Inducible skin-associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema.
    Br J Dermatol. 2021 Jan 14. doi: 10.1111/bjd.19808.
    >> Share


  308. Revolutionizing Atopic Dermatitis, 13-14 December 2020.
    Br J Dermatol. 2021 Jan 11. doi: 10.1111/bjd.19722.
    >> Share

  309. ABADIAS-GRANADO I, Navarro-Bielsa A, Morales-Callaghan AM, Roc L, et al
    COVID-19-associated cutaneous manifestations: does HHV-6 play an etiological role?
    Br J Dermatol. 2021 Jan 8. doi: 10.1111/bjd.19806.
    >> Share

  310. GIANOTTI R, Barberis M, Fellegara G, Galvan-Casas C, et al
    COVID-19 related dermatosis in November 2019. Could this case be Italy's patient zero?
    Br J Dermatol. 2021 Jan 7. doi: 10.1111/bjd.19804.
    >> Share

  311. KELLY A, Meurling J, Kirthi Jeyarajah S, Ryan C, et al
    Obstructive Sleep Apnea in Psoriasis and Hidradenitis Suppurativa.
    Br J Dermatol. 2021 Jan 6. doi: 10.1111/bjd.19802.
    >> Share

  312. LAN Y, Zeng W, Dong X, Lu H, et al
    Opsin 5 is a key regulator of ultraviolet radiation induced melanogenesis in human epidermal melanocytes.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19797.
    >> Share

  313. ZHU JL, Tran LT, Smith M, Zheng F, et al
    Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19800.
    >> Share

  314. LOH AYT, Ho CM, Muthiah S, Venkatesh B, et al
    Huriez syndrome caused by a large deletion that abrogates the skin-specific isoform of SMARCAD1.
    Br J Dermatol. 2021 Jan 5. doi: 10.1111/bjd.19799.
    >> Share

  315. MEYER JM, Lee E, Celli A, Park K, et al
    CERKL is upregulated in cutaneous squamous cell carcinoma and maintains cellular sphingolipids and resistance to oxidative stress.
    Br J Dermatol. 2021 Jan 4. doi: 10.1111/bjd.19753.
    >> Share

  316. GAULT A, Anderson AE, Plummer R, Stewart C, et al
    Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors.
    Br J Dermatol. 2021 Jan 4. doi: 10.1111/bjd.19750.
    >> Share

  317. SOARES CD, Mosqueda-Taylor A, de Carvalho MGF, de Almeida OP, et al
    Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.
    Br J Dermatol. 2021;184:e6.
    >> Share

  318. DERRICK KM, Mazori DR, Heilman ER, Glick SA, et al
    Prurigo pigmentosa and new-onset type 1 diabetes in a black female patient testing positive for SARS-CoV-2 IgG.
    Br J Dermatol. 2021;184:e5.
    >> Share

  319. NUNO-GONZALEZ A, Martin-Carrillo P, Magaletsky K, Martin Rios MD, et al
    Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings.
    Br J Dermatol. 2021;184:184-185.
    >> Share

  320. LIMA XT, Cueva MA, Alora MB
    COVID-19 in patients with hidradenitis suppurativa.
    Br J Dermatol. 2021;184:182-184.
    >> Share

  321. FERGUSON FJ, Street G, Cunningham L, White IR, et al
    Occupational dermatology in the time of the COVID-19 pandemic: a report of experience from London and Manchester, UK.
    Br J Dermatol. 2021;184:180-182.
    >> Share

  322. MAGRO CM, Mulvey JJ, Laurence J, Sanders S, et al
    The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
    Br J Dermatol. 2021;184:141-150.
    >> Share

  323. CHEN E, Ghannoum M, Elewski BE
    Treatment-resistant tinea corporis, a potential public health issue.
    Br J Dermatol. 2021;184:164-165.
    >> Share


  324. Trim21 promotes inflammation in keratinocytes of psoriatic patients.
    Br J Dermatol. 2021;184:e7-e28.
    >> Share

  325. OHYAMA M
    Caffeine relaxes hair follicles in androgenetic alopecia.
    Br J Dermatol. 2021;184:7-8.
    >> Share

  326. GUPTA V, Taneja N, Sati HC, Sreenivas V, et al
    Evaluation of 'not relevant' responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo.
    Br J Dermatol. 2021;184:168-169.
    >> Share

  327. EXPOSITO-SERRANO V, Curto-Barredo L, Aguilera Peiro P, Gomez Armayones S, et al
    Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
    Br J Dermatol. 2021;184:167-168.
    >> Share

  328. NARAYAN VS, Uitentuis SE, Bekkenk MW, Wolkerstorfer A, et al
    What is successful repigmentation in vitiligo from the point of view of patients?
    Br J Dermatol. 2021;184:165-166.
    >> Share

  329. FERNANDEZ JM, Thompson AM, Kirby JS, Hsiao JL, et al
    Characterizing physical symptoms of flare in hidradenitis suppurativa: a patient survey.
    Br J Dermatol. 2021;184:160-162.
    >> Share

  330. BOONCHAI W
    What should be in the facial patch testing series for 2020?
    Br J Dermatol. 2021;184:13.
    >> Share

  331. BAX CE, Werth VP
    The incidence of bullous pemphigoid continues to increase in England.
    Br J Dermatol. 2021;184:5-6.
    >> Share

  332. ZOUBOULIS CC
    First real-world data provide evidence for a 'window of opportunity' in treatment of hidradenitis suppurativa/acne inversa.
    Br J Dermatol. 2021;184:10-11.
    >> Share

  333. PERSSON MSM, Harman KE, Vinogradova Y, Langan SM, et al
    Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study.
    Br J Dermatol. 2021;184:68-77.
    >> Share

  334. MARZANO AV, Genovese G, Casazza G, Moltrasio C, et al
    Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
    Br J Dermatol. 2021;184:133-140.
    >> Share

  335. INGRAM JR, Ahluwalia A
    The pharmacology of itch.
    Br J Dermatol. 2021;184:e1-e2.
    >> Share

    December 2020
  336. TOLAND AE
    The influence of sex, age and sunlight exposure on mutational processes in melanoma.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19336.
    >> Share

  337. VAN DER KRAAIJ GE, van Huizen AM, Baerveldt EM, Boshuizen M, et al
    Online decision aid for patients with psoriasis.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19761.
    >> Share

  338. JI-XU A, Dinnes J, Matin RN
    Total Body Photography for the Diagnosis of Cutaneous Melanoma in Adults: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2020 Dec 28. doi: 10.1111/bjd.19759.
    >> Share

  339. MAHIL SK, Yates M, Langan SM, Yiu ZZN, et al
    Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
    Br J Dermatol. 2020 Dec 23. doi: 10.1111/bjd.19755.
    >> Share

  340. PUIG L
    Head-to-head comparison of biologics in psoriasis: better acceleration does not necessarily win all races.
    Br J Dermatol. 2020 Dec 21. doi: 10.1111/bjd.19696.
    >> Share

  341. MORRA DE, Drucker AM
    Tralokinumab for atopic dermatitis: a promising new therapy.
    Br J Dermatol. 2020 Dec 21. doi: 10.1111/bjd.19699.
    >> Share

  342. KASSARDJIAN AA, Chat VS, Archuleta L, Hekmatjah J, et al
    Words Matter: A randomized controlled study evaluating the impact of decision-framing on treatment preferences in adults with psoriasis and psoriatic arthritis.
    Br J Dermatol. 2020 Dec 17. doi: 10.1111/bjd.19746.
    >> Share

  343. HAMM H, Wilsmann-Theis D, Tsianakas A, Gambichler T, et al
    Efficacy and safety of fumaric acid esters in young patients aged 10 to 17 years with moderate-to-severe plaque psoriasis - A randomised, double-blinded, placebo-controlled trial.
    Br J Dermatol. 2020 Dec 17. doi: 10.1111/bjd.19747.
    >> Share

  344. GREIG A, Aloni K, Orchard G, Shams M, et al
    Treatment of multiple facial basal cell carcinomas in a child with xeroderma pigmentosum complementation group C with Mohs micrographic surgery.
    Br J Dermatol. 2020 Dec 16. doi: 10.1111/bjd.19323.
    >> Share

  345. TOBIN DJ
    Unpicking the Gordian knot of identifying metastasis development-relevant proteins in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Dec 16. doi: 10.1111/bjd.19697.
    >> Share

  346. RUINI C, Schuh S, Hartmann D, French L, et al
    Noninvasive real-time imaging of mite skin infestations with line-field confocal optical coherence tomography.
    Br J Dermatol. 2020 Dec 14. doi: 10.1111/bjd.19318.
    >> Share

  347. BERGQVIST C, Stern RS, Chosidow O
    Psoriasis: an example of the complexity of decision-making.
    Br J Dermatol. 2020 Dec 10. doi: 10.1111/bjd.19715.
    >> Share

  348. GEHLHAUSEN JR, Ko CJ, Damsky W
    Response to Tembhre et al.: 'Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2'.
    Br J Dermatol. 2020 Dec 10. doi: 10.1111/bjd.19714.
    >> Share

  349. DESCALZO MA, Garcia-Doval I
    Association of skin diseases, biological treatment and COVID-19 during the first wave of the pandemic.
    Br J Dermatol. 2020 Dec 4. doi: 10.1111/bjd.19683.
    >> Share

  350. MEYER JM, Lee E, Celli A, Park K, et al
    CERKL is Upregulated in Cutaneous Squamous Cell Carcinoma and Maintains Cellular Sphingolipids and Resistance to Oxidative Stress.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19707.
    >> Share

  351. VUONG K, Armstrong BK, Espinoza D, Hopper JL, et al
    An independent external validation of melanoma risk prediction models using the Australian Melanoma Family Study.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19706.
    >> Share

  352. LASKAR R, Ferreiro-Iglesias A, Bishop DT, Iles MM, et al
    Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.
    Br J Dermatol. 2020 Dec 3. doi: 10.1111/bjd.19705.
    >> Share

  353. MCALEER MA, Jakasa I, Stefanovic N, McLean WHI, et al
    Topical Corticosteroids Normalize both Skin and Systemic Inflammatory Markers in Infant Atopic Dermatitis.
    Br J Dermatol. 2020 Dec 2. doi: 10.1111/bjd.19703.
    >> Share

  354. PAN CX, Jee YH, Moore KJ, Kraft P, et al
    Relationship Between Body Mass Index and Atopic Dermatitis: Critical Appraisal of a Mendelian Randomization Approach in Exploring Causality.
    Br J Dermatol. 2020 Dec 1. doi: 10.1111/bjd.19702.
    >> Share

  355. BABAKINEJAD P, Hampton PJ
    New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens?
    Br J Dermatol. 2020;183:984-985.
    >> Share


  356. Why don't people with psoriasis take enough exercise?
    Br J Dermatol. 2020;183:e191-e200.
    >> Share

  357. PENDSE RS, Schwartz BL, Jia JL, Bailey EE, et al
    Paucity of COVID-19 dermatology literature from low- and middle-income countries.
    Br J Dermatol. 2020;183:1142-1143.
    >> Share

  358. XU R, Zhou Y, Cai L, Wang L, et al
    Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19.
    Br J Dermatol. 2020;183:1145-1147.
    >> Share

  359. RENCZ F
    A new self-reported measure of disease severity of scalp hair loss in alopecia areata.
    Br J Dermatol. 2020;183:986-987.
    >> Share

    November 2020
  360. BESSIS D
    Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window.
    Br J Dermatol. 2020 Nov 29. doi: 10.1111/bjd.19596.
    >> Share

  361. OEI W, Fledderus AC, Spuls PI, Eggen CAM, et al
    Development of an international core domain set for medium, large and giant congenital melanocytic nevi as a first step towards a core outcome set for clinical practice and research.
    Br J Dermatol. 2020 Nov 25. doi: 10.1111/bjd.19694.
    >> Share

  362. REYNOLDS KA, Schlessinger DI, Yanes AF, Godinez-Puig V, et al
    Development of a Core Outcome Set for Cutaneous Squamous Cell Carcinoma Trials: Identification of Core Domains and Outcomes.
    Br J Dermatol. 2020 Nov 25. doi: 10.1111/bjd.19693.
    >> Share

  363. REICH K, Sorbe C, Griese L, Reich JLK, et al
    The value of subcutaneous versus oral methotrexate - real-world data from the German psoriasis registry PsoBest.
    Br J Dermatol. 2020 Nov 21. doi: 10.1111/bjd.19690.
    >> Share

  364. PATEL S, Cadwell JB, Lambert WC
    Comparison of adult versus paediatric staphylococcal scalded skin syndrome inpatients: A retrospective database analysis.
    Br J Dermatol. 2020 Nov 20. doi: 10.1111/bjd.19691.
    >> Share

  365. NAKAMURA M, Obayashi M, Yoshimitsu M, Kato H, et al
    Comparative whole-exome sequencing of an ultra-late recurrent malignant melanoma.
    Br J Dermatol. 2020 Nov 18. doi: 10.1111/bjd.19680.
    >> Share

  366. LICHTER J, Silva E Sousa M, Peter N, Sahli F, et al
    Skin sensitisation to fragrance hydroperoxides: interplay between dendritic cells, keratinocytes and free radicals.
    Br J Dermatol. 2020 Nov 18. doi: 10.1111/bjd.19685.
    >> Share

  367. ZIAJ S, Tseliou F, Datta D, Abbott RA, et al
    Skin cancer awareness and prevention behaviour in Wales.
    Br J Dermatol. 2020 Nov 11. doi: 10.1111/bjd.19676.
    >> Share

  368. GROOT J, Blegvad C, Nybo Andersen AM, Zachariae C, et al
    Presence of streptococci and frequent tonsillitis among adolescents with psoriasis.
    Br J Dermatol. 2020 Nov 10. doi: 10.1111/bjd.19672.
    >> Share

  369. MIYANO T, Tanaka RJ
    Identification of keratinocyte subpopulations in transcriptome to evaluate drug effects in atopic dermatitis.
    Br J Dermatol. 2020 Nov 8. doi: 10.1111/bjd.19615.
    >> Share

  370. VAZQUEZ T, Concha JSS, Werth VP
    Patient-oriented outcomes for atopic dermatitis.
    Br J Dermatol. 2020 Nov 8. doi: 10.1111/bjd.19614.
    >> Share

  371. VERMEER MH, Nicolay JP, Scarisbrick JJ, Zinzani PL, et al
    The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
    Br J Dermatol. 2020 Nov 6. doi: 10.1111/bjd.19669.
    >> Share

  372. TEMBHRE MK, Parihar AS, Sharma VK, Imran S, et al
    Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2.
    Br J Dermatol. 2020 Nov 6. doi: 10.1111/bjd.19670.
    >> Share

  373. VAN WINDEN MEC, Ter Haar ELM, Groenewoud JMM, van de Kerkhof PCM, et al
    Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups.
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19665.
    >> Share

  374. BRAHMBHATT HD, Gupta R, Gupta A, Rastogi S, et al
    Long non-coding RNA MALAT1 suppresses miR-211 to confer protection from UV-mediated DNA damage in vitiligo epidermis by upregulating SIRT1.
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19666.
    >> Share

  375. MURRAY G, Roche D, Ridge A, Hackett C, et al
    Response to "Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic".
    Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19667.
    >> Share

  376. KEOHANE SG, Botting J, Budny PG, Dolan OM, et al
    British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.
    Br J Dermatol. 2020 Nov 4. doi: 10.1111/bjd.19621.
    >> Share

  377. PATALAY R
    Which method is better for the diagnosis of basal cell carcinoma: biopsy vs. reflectance confocal microscopy?
    Br J Dermatol. 2020 Nov 2. doi: 10.1111/bjd.19571.
    >> Share


  378. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS((R)) ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.
    Br J Dermatol. 2020;183:e149-e170.
    >> Share

  379. SIMONSEN AB, Ruge IF, Quaade AS, Johansen JD, et al
    High incidence of hand eczema in Danish schoolchildren following intensive hand hygiene during the COVID-19 pandemic: a nationwide questionnaire study.
    Br J Dermatol. 2020;183:975-976.
    >> Share

  380. VAN DELFT LCJ, Essers BAB, Nelemans PJ, Mosterd K, et al
    Development of a patient decision aid for superficial basal-cell carcinoma.
    Br J Dermatol. 2020 Nov 1. doi: 10.1111/bjd.19662.
    >> Share

  381. WANG HL, Sun J, Qian ZM, Gong YQ, et al
    Association between Air Pollution and Atopic Dermatitis in Guangzhou, China: Modification by Age and Season.
    Br J Dermatol. 2020 Nov 1. doi: 10.1111/bjd.19645.
    >> Share

  382. ELEWSKI B
    A call for antifungal stewardship.
    Br J Dermatol. 2020;183:798-799.
    >> Share

  383. MATOS TR
    Is targeting circulating T blood cells a therapeutic option for vitiligo?
    Br J Dermatol. 2020;183:803.
    >> Share

  384. SCHUTTELAAR MLA
    The value of ongoing surveillance on the prevalence of contact sensitization.
    Br J Dermatol. 2020;183:800-801.
    >> Share

  385. ELEFTHERIADOU V
    Reliability and validity of the Vitiligo Signs of Activity Score.
    Br J Dermatol. 2020;183:801-802.
    >> Share

  386. KIRBY B, Fitzgerald O
    A new biomarker for psoriatic arthritis?
    Br J Dermatol. 2020;183:805-806.
    >> Share

  387. BELLON T, Kardaun SH
    CXCL10/IP-10, an early biomarker for late sequelae in DRESS?
    Br J Dermatol. 2020;183:804-805.
    >> Share

    October 2020
  388. NOLAN GS, Kiely AL, Totty JP, Wormald J, et al
    Incomplete surgical excision of keratinocyte skin cancers: a systematic review and meta-analysis.
    Br J Dermatol. 2020 Oct 31. doi: 10.1111/bjd.19660.
    >> Share

  389. DOBOS G, de Masson A, Ram-Wolff C, Beylot-Barry M, et al
    Epidemiological changes in cutaneous lymphomas: an analysis of 8,593 patients from the French Cutaneous Lymphoma Registry.
    Br J Dermatol. 2020 Oct 31. doi: 10.1111/bjd.19644.
    >> Share

  390. SEARS AV, Woolf RT, Gribaleva E, Abdelrahman W, et al
    Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one-year observational cohort study of the first 100 patients treated.
    Br J Dermatol. 2020 Oct 27. doi: 10.1111/bjd.19631.
    >> Share

  391. CHARVET E, Kramkimel N, Chaplain L, Gantzer A, et al
    Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-PD-1 monoclonal antibodies.
    Br J Dermatol. 2020 Oct 24. doi: 10.1111/bjd.19629.
    >> Share

  392. IVERT LU, Wahlgren CF, Lindelof B, Dal H, et al
    Association between atopic dermatitis and autoimmune diseases: a population-based case-control study.
    Br J Dermatol. 2020 Oct 22. doi: 10.1111/bjd.19624.
    >> Share

  393. MARUTHAPPU T, Bewley A
    A changed life: the life experiences of patients with psoriasis receiving biological treatment.
    Br J Dermatol. 2020 Oct 21. doi: 10.1111/bjd.19623.
    >> Share

  394. WOLINER-VAN DER WEG W, Peppelman M, van Erp PEJ, Lubeek SFK, et al
    Lost in translation: True Clinical Impact of RCM Overlooked in "Biopsy outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial": reply from au
    Br J Dermatol. 2020 Oct 15. doi: 10.1111/bjd.19605.
    >> Share

  395. GILL M, Pellacani G, Grant-Kels JM, Ardigo M, et al
    Lost in Translation: True Clinical Impact of RCM Overlooked in "Biopsy outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial".
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19602.
    >> Share

  396. SORIANO LF, Bertram CG, Chowdhury MMU, Cousen P, et al
    Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland.
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19603.
    >> Share

  397. GHIASVAND R, Khosrotehrani K, Hughes MCB, von Schuckmann LA, et al
    Patient age and risk of recurrence of primary melanoma at high risk of spread.
    Br J Dermatol. 2020 Oct 14. doi: 10.1111/bjd.19601.
    >> Share

  398. SCHMITT-EGENOLF M
    Complete skin clearance and beyond.
    Br J Dermatol. 2020 Oct 8. doi: 10.1111/bjd.19544.
    >> Share

  399. LAUGHTER MR, Maymone MBC, Mashayekhi S, Arents BWM, et al
    The global burden of atopic dermatitis: lessons from the GBD Study - 1990 to 2017.
    Br J Dermatol. 2020 Oct 2. doi: 10.1111/bjd.19580.
    >> Share

  400. REICH K
    A new treatment option for paediatric psoriasis.
    Br J Dermatol. 2020;183:606-607.
    >> Share

  401. CASELLI D, Chironna M, Loconsole D, Nigri L, et al
    No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
    Br J Dermatol. 2020;183:784-785.
    >> Share

  402. NAIK HB, Alhusayen R, Frew J, Guilbault S, et al
    Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices.
    Br J Dermatol. 2020;183:780-781.
    >> Share

  403. SANTONJA C, Heras F, Nunez L, Requena L, et al
    COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
    Br J Dermatol. 2020;183:778-780.
    >> Share

  404. COLMENERO I, Santonja C, Alonso-Riano M, Noguera-Morel L, et al
    SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Br J Dermatol. 2020;183:729-737.
    >> Share

  405. MOHD MUSTAPA MF, de Berker D, McGregor JM, Exton LS, et al
    Suspension of marketing authorization for ingenol mebutate.
    Br J Dermatol. 2020;183:792.
    >> Share

  406. POPE E
    Epidermolysis bullosa: a 2020 perspective.
    Br J Dermatol. 2020;183:603.
    >> Share

  407. BLOME C
    Percentage of scalp-hair loss as a primary endpoint in alopecia areata trials.
    Br J Dermatol. 2020;183:609.
    >> Share

  408. CLARK KEN, Denton CP
    The patient knows best: a new self-reported outcome measure for systemic sclerosis.
    Br J Dermatol. 2020;183:610.
    >> Share

  409. STEEB T, Heppt MV, Berking C
    Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
    Br J Dermatol. 2020;183:612.
    >> Share

  410. HAUGAARD JH, Egeberg A
    Do we need to fear methotrexate?
    Br J Dermatol. 2020;183:608-609.
    >> Share

    September 2020
  411. SILVERBERG JI, Toth D, Bieber T, Alexis AF, et al
    Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19573.
    >> Share

  412. WOLLENBERG A, Blauvelt A, Guttman-Yassky E, Worm M, et al
    Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19574.
    >> Share

  413. REDDY R, Pannu S, Fiumara K, Kahn J, et al
    Efficacy of in-class IL-23 inhibitor switching: Risankizumab following Guselkumab failure in moderate-to-severe psoriasis treatment.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19575.
    >> Share

  414. NETTIS E, Fabbrocini G, Ortoncelli M, Pellacani G, et al
    Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients.
    Br J Dermatol. 2020 Sep 30. doi: 10.1111/bjd.19577.
    >> Share

  415. CORK MJ, Thaci D, Eichenfield LF, Arkwright PD, et al
    Dupilumab provides favourable long-term safety and efficacy in children aged >/= 6 to < 12 years with uncontrolled, severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.
    Br J Dermatol. 2020 Sep 24. doi: 10.1111/bjd.19460.
    >> Share

  416. POLAK ME
    Early life regulation of inflammation in atopic dermatitis by microRNA.
    Br J Dermatol. 2020 Sep 20. doi: 10.1111/bjd.19475.
    >> Share

  417. JOHNSON MC, Heron CE, Feldman SR
    Long-term efficacy of certolizumab pegol for psoriasis.
    Br J Dermatol. 2020 Sep 20. doi: 10.1111/bjd.19537.
    >> Share

  418. LEUTZ A, Pinter A, Thaci D, Augustin M, et al
    Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment.
    Br J Dermatol. 2020 Sep 17. doi: 10.1111/bjd.19558.
    >> Share

  419. VALENTIN F, Wiegmann H, Tarinski T, Nikolenko H, et al
    Development of a Pathogenesis-Based Therapy for Peeling Skin Syndrome Type 1.
    Br J Dermatol. 2020 Sep 14. doi: 10.1111/bjd.19546.
    >> Share

  420. SALMAN A
    What determines the treatment persistence in paediatric psoriasis?
    Br J Dermatol. 2020 Sep 10. doi: 10.1111/bjd.19436.
    >> Share

  421. DELALEU J, Battistella M, Rathana K, Vignon-Pennamen MD, et al
    Identification of Clonal Skin Myeloid Cells by Next Generation Sequencing in Myelodysplasia Cutis.
    Br J Dermatol. 2020 Sep 10. doi: 10.1111/bjd.19547.
    >> Share

  422. THOMPSON LL, Chang MS, McCormack L, Polyakov N, et al
    Patterns of cutaneous immune-related adverse events in adults and children with advanced sarcoma: A retrospective cohort study.
    Br J Dermatol. 2020 Sep 7. doi: 10.1111/bjd.19540.
    >> Share

  423. MIRZA FN, Yumeen S, Walter FM
    The Epidemiology of Malignant Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma in the United Kingdom from 2004-2014: A Population-Based Cohort Analysis using the Clinical Practice Research Datalink.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19542.
    >> Share

  424. FANG MM, Nowinski CJ, Lai J, Shaunfield S, et al
    Characteristics and Impacts of Itch in Children with Inflammatory Skin Disorders.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19541.
    >> Share

  425. THOMPSON LL, Chen ST
    Tocilizumab and other targeted therapies for severe cutaneous immune-related adverse events.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19322.
    >> Share

  426. MOSTAFA A, Murata T, Kabashima K
    Light in the dark: distinct effects of dimethyl fumarate on different T-cell subsets in psoriasis treatment.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19407.
    >> Share

  427. ELSARAFY S, Tobiss H, Veitch D, Bhuchar M, et al
    Ruptured hair follicles of the scalp mimicking malignant melanoma.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19476.
    >> Share

  428. NAVARRO-NAVARRO I, Jimenez-Gallo D, Valenzuela-Ubina S, Dominguez-Gomez M, et al
    Infantile bullous pemphigoid following serogroup B meningococcal vaccination.
    Br J Dermatol. 2020 Sep 6. doi: 10.1111/bjd.19480.
    >> Share

  429. CHO SI, Kim YE, Jo SJ
    Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.
    Br J Dermatol. 2020 Sep 2. doi: 10.1111/bjd.19507.
    >> Share

  430. DAVILA-SEIJO P
    Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed.
    Br J Dermatol. 2020 Sep 2. doi: 10.1111/bjd.19434.
    >> Share

  431. BLAUVELT A, Leonardi C, Elewski B, Crowley JJ, et al
    A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 24-Week Efficacy and Safety Results from a Randomised, Double-Blinded Trial.
    Br J Dermatol. 2020 Sep 2. doi: 10.1111/bjd.19509.
    >> Share


  432. Assessing work-related productivity loss and indirect costs of psoriasis across six countries.
    Br J Dermatol. 2020;183:e65-e90.
    >> Share

  433. GABES M
    Are existing quality-of-life instruments in cutaneous T-cell lymphoma of sufficient quality?
    Br J Dermatol. 2020 Sep 1. doi: 10.1111/bjd.19408.
    >> Share

  434. ORMEROD AD
    Spoiled for choice? Are you confused by the number of biological options for psoriasis?
    Br J Dermatol. 2020 Sep 1. doi: 10.1111/bjd.19401.
    >> Share

  435. KORKMAZ P, Boyvat A
    The importance of provided information in contact allergy: key predictors on the road to success in the control of allergic contact dermatitis.
    Br J Dermatol. 2020 Sep 1. doi: 10.1111/bjd.19432.
    >> Share

  436. KIM Y, Jorgenson E, Asgari MM
    Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.
    Br J Dermatol. 2020;183:415-416.
    >> Share

  437. HAMPTON PJ
    Expanding treatment options for rosacea.
    Br J Dermatol. 2020;183:412-413.
    >> Share

  438. DRABO EF, Levy JF, Gaskin DJ
    Yes, accurately measuring and valuing health-related productivity loss is important, but can we afford any longer not to prevent and address it?
    Br J Dermatol. 2020;183:420-421.
    >> Share

  439. PATTINSON R, Bundy C
    Self-management: PROMs can prompt support.
    Br J Dermatol. 2020;183:418-419.
    >> Share

    August 2020
  440. GAWKRODGER DJ, Hunter JAA
    Skin disease case mix in the early 1920s: diagnoses prevalent at the time of the founding of the British Association of Dermatologists.
    Br J Dermatol. 2020 Aug 31. doi: 10.1111/bjd.19506.
    >> Share

  441. MALHI IS, Yiu ZZN
    Algorithm based smartphone apps to assess risk of skin cancer in adults: critical appraisal of a systematic review.
    Br J Dermatol. 2020 Aug 31. doi: 10.1111/bjd.19502.
    >> Share

  442. OLSEN CM, Pandeya N, Dusingize JC, Thompson BS, et al
    Reproductive factors, hormone use and melanoma risk: an Australian prospective cohort study.
    Br J Dermatol. 2020 Aug 27. doi: 10.1111/bjd.19498.
    >> Share

  443. MULDER EEAP, Dwarkasing JT, Tempel D, van A, et al
    Validation of a Clinicopathological and Gene Expression Profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma.
    Br J Dermatol. 2020 Aug 26. doi: 10.1111/bjd.19499.
    >> Share

  444. WADE R, Sharif-Hurst S, Smith C, Dias S, et al
    Characteristics modifying response to biologic treatments for psoriasis: considering subgroups in network meta-analysis.
    Br J Dermatol. 2020 Aug 19. doi: 10.1111/bjd.19494.
    >> Share

  445. D'INCAN M, Ingen-Housz-Oro S, Beylot-Barry M, Joly P, et al
    Locoregional nodal extension does not impair prognosis of primary cutaneous anaplastic lymphomas.
    Br J Dermatol. 2020 Aug 18. doi: 10.1111/bjd.19495.
    >> Share

  446. CHIRICO A, Henderson Berg MH, Roberge D, Pehr K, et al
    Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma.
    Br J Dermatol. 2020 Aug 15. doi: 10.1111/bjd.19490.
    >> Share

  447. SHAPANIS A, Lai C, Smith S, Coltart G, et al
    Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.
    Br J Dermatol. 2020 Aug 13. doi: 10.1111/bjd.19485.
    >> Share

  448. DE BENEDETTO A
    Tight junctions in the skin: still a lot to learn.
    Br J Dermatol. 2020 Aug 10. doi: 10.1111/bjd.19390.
    >> Share

  449. MAHON C, McHugh K, Alband N, Rampling D, et al
    Routine liver ultrasound screening does not alter clinical management in a cohort study of multiple cutaneous infantile haemangioma.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19472.
    >> Share

  450. LONG F, He F, Wang J, Wang L, et al
    Nail fold capillary abnormalities: a possible cause for nail psoriasis?
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19466.
    >> Share

  451. KIM HS, Ahn HS
    Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea': reply from authors.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19465.
    >> Share

  452. CALEY MP, Martins VL, Moore K, Lashari M, et al
    Loss of Laminin alpha3 induces cell invasion and macrophage infiltration in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19471.
    >> Share

  453. REDDY VD, Myers BA, Chan SY, Thibodeaux QG, et al
    A review of current phase III clinical trials of plaque psoriasis: Underrepresentation of non-white subjects and need for reform.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19468.
    >> Share

  454. TOUSSAINT F, Erdmann M, Grosch E, Schliep S, et al
    Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19470.
    >> Share

  455. HINDELANG B, Aguirre J, Berezhnoi A, Biedermann T, et al
    Quantification of skin sensitivity to ultraviolet radiation using ultra-wideband optoacoustic mesoscopy.
    Br J Dermatol. 2020 Aug 6. doi: 10.1111/bjd.19463.
    >> Share

  456. NAPOLITANO M, Caiazzo G, Fabbrocini G, Balato A, et al
    Increased expression of IL-23A in lesional skin of atopic dermatitis patients with psoriasiform reaction during dupilumab treatment.
    Br J Dermatol. 2020 Aug 6. doi: 10.1111/bjd.19464.
    >> Share

  457. RUSSELL E, Walker S, McPherson T
    Diagnosis of Mycoplasma aetiology in Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.
    Br J Dermatol. 2020 Aug 5. doi: 10.1111/bjd.19458.
    >> Share

  458. SILVERBERG JI, Lei D, Yousaf M, Janmohamed SR, et al
    What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study.
    Br J Dermatol. 2020 Aug 5. doi: 10.1111/bjd.19457.
    >> Share

  459. SAMIMI M, Kelleners-Smeets N
    Innovative devices for actinic keratoses: a hot-button issue.
    Br J Dermatol. 2020;183:197-199.
    >> Share

  460. NIXON J
    Silicone dressings for pressure ulcer prevention.
    Br J Dermatol. 2020;183:200-201.
    >> Share

  461. PRIOR J
    Understanding how young people perceive acne and acne treatments.
    Br J Dermatol. 2020;183:208-209.
    >> Share

  462. MEIER K, Ghoreschi K
    Among the brightest antipsoriatic stars.
    Br J Dermatol. 2020;183:201-202.
    >> Share

  463. MAGIN P
    A novel approach to understanding potential risk factors for venous leg ulceration.
    Br J Dermatol. 2020;183:207-208.
    >> Share

  464. ARENTS BWM, Leonardi-Bee J
    Eczema and water hardness: another piece of the puzzle found?
    Br J Dermatol. 2020;183:203-204.
    >> Share

  465. PATEL ZS, Hoffman LK, Sutton L, Cohen SR, et al
    The patient experience of pain in hidradenitis suppurativa.
    Br J Dermatol. 2020;183:401-402.
    >> Share

    July 2020
  466. SPEECKAERT R, Lambert J, Delbaere L, Lesseliers T, et al
    The reliability of the self-assessment cutaneous inflammatory disease extent score (SA-CIDES) and the rule of hands to assess the involved body surface area in psoriasis and eczema.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19430.
    >> Share

  467. KITTLER H, Tschandl P, Weninger W
    Cutaneous signs in SARS CoV-2 infection: A plea for more rigorous peer-review in the time of COVID-19.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19429.
    >> Share

  468. CLAYTON K, Vallejo A, Sirvent S, Davies J, et al
    Machine learning applied to atopic dermatitis transcriptome reveals distinct therapy-dependent modification of the keratinocyte immunophenotype.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19431.
    >> Share

  469. PEREYRA-RODRIGUEZ JJ, Dominguez-Cruz J, Ruiz-Villaverde R, Silvestre JF, et al
    Drug survival of systemic and biologic treatments for moderate-to-severe atopic dermatitis in adults: a multicenter retrospective observational study.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19428.
    >> Share

  470. MIRZA FN, Yumeen S, Girardi M
    Disparities in Outcomes of CD8(+) Cutaneous T Cell Lymphoma by Race and Presenting Lesion Location.
    Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19426.
    >> Share

  471. WILKINSON MJ, Gyorki DE
    Extent of ulceration in cutaneous melanoma: is this biomarker ready for primetime?
    Br J Dermatol. 2020 Jul 29. doi: 10.1111/bjd.19386.
    >> Share

  472. DAYAL JHS, Mason SM, Salas-Alanis JC, McGrath JA, et al
    Heterogeneous addiction to TGFbeta signalling in recessive dystrophic epidermolysis bullosa associated cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Jul 29. doi: 10.1111/bjd.19421.
    >> Share

  473. GLOOR AD, Feldmeyer L, Rammlmair A, Schlapbach C, et al
    A relapsing localized variant of neutrophilic dermatosis triggered by tissue injury.
    Br J Dermatol. 2020 Jul 29. doi: 10.1111/bjd.19418.
    >> Share

  474. RAFEI-SHAMSABADI D
    GNAQ/11 mutant nonuveal melanoma: same same but different.
    Br J Dermatol. 2020 Jul 28. doi: 10.1111/bjd.19335.
    >> Share

  475. JIANG X, Lin Z, Wang H
    Multiple lentigines and cutaneous hyperpigmentation caused by a KIT mutation.
    Br J Dermatol. 2020 Jul 27. doi: 10.1111/bjd.19295.
    >> Share

  476. SMRKE A, Benson C
    Eribulin for recurrent cutaneous angiosarcoma.
    Br J Dermatol. 2020 Jul 27. doi: 10.1111/bjd.19333.
    >> Share

  477. LANGTRY J, Rajan N
    Pre-emptive intra-auricular electrosurgical resurfacing of cylindromas to prevent conductive deafness in CYLD cutaneous syndrome.
    Br J Dermatol. 2020 Jul 27. doi: 10.1111/bjd.19331.
    >> Share

  478. SHEEN YS, Chu CY
    Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma.
    Br J Dermatol. 2020 Jul 22. doi: 10.1111/bjd.19416.
    >> Share

  479. O'SHAUGHNESSY RFL
    Ubiquitin, a novel therapeutic target in psoriasis?
    Br J Dermatol. 2020 Jul 21. doi: 10.1111/bjd.19332.
    >> Share

  480. DURACK A, Holden ST, Burrows NP
    Congenital bilateral scar-like lesions on the face.
    Br J Dermatol. 2020 Jul 21. doi: 10.1111/bjd.19328.
    >> Share

  481. BEHBAHANI S, Malerba S, Samie FH
    Racial and Ethnic Differences in the Clinical Presentation and Outcomes of Acral Lentiginous Melanoma.
    Br J Dermatol. 2020 Jul 19. doi: 10.1111/bjd.19406.
    >> Share

  482. DRUCKER AM
    Is baricitinib up next for atopic dermatitis?
    Br J Dermatol. 2020 Jul 13. doi: 10.1111/bjd.19226.
    >> Share

  483. GOETH H, Koller M, Hegemann MV, Drexler K, et al
    Active versus standard sun protection in patients with melanoma stage I or II: A randomised controlled feasibility trial assessing compliance with sun protection and quality of life.
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19395.
    >> Share

  484. BAI X, Flaherty KT
    Targeted and immunotherapies in BRAF mutant melanoma - where we are standing and what to expect.
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19394.
    >> Share

  485. REICH A
    Reliable assessment of atopic dermatitis severity: do we need more tools?
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19392.
    >> Share

  486. GORDON KB, Warren RB, Gottlieb AB, Blauvelt A, et al
    Long-Term Efficacy of Certolizumab Pegol for the Treatment of Plaque Psoriasis: Three-Year Results from Two Randomised Phase 3 Trials (CIMPASI-1 and CIMPASI-2).
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19393.
    >> Share

  487. REICH K, Korber A, Mrowietz U, Sticherling M, et al
    Secukinumab two weekly versus four weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study.
    Br J Dermatol. 2020 Jul 11. doi: 10.1111/bjd.19398.
    >> Share

  488. NUSSBAUM L, Chen YL, Ogg GS
    Role of regulatory T cells in psoriasis pathogenesis and treatment.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19380.
    >> Share

  489. WOLINER-VAN DER WEG W, Peppelman M, Elshot YS, Visch MB, et al
    Biopsy Outperforms Reflectance Confocal Microscopy in Diagnosing and Subtyping Basal Cell Carcinoma: Results and Experiences from a Randomized Controlled Multicentre Trial.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19381.
    >> Share

  490. PEINEMANN F, Harari M, Peternel S, Chan T, et al
    Indoor salt water baths followed by artificial ultraviolet B-light for chronic plaque psoriasis: abridged Cochrane review.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19385.
    >> Share

  491. ALFONSO JH, Martinsen JI, Weiderpass E, Pukkala E, et al
    Occupation and cutaneous melanoma: a 45-year historical cohort study of 14.9 million people in five Nordic countries.
    Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19379.
    >> Share

  492. HAY RJ
    A viral rash: the impact of COVID-19 infection on the skin.
    Br J Dermatol. 2020;183:1-2.
    >> Share


  493. A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis.
    Br J Dermatol. 2020;183:e4-e30.
    >> Share

  494. LIM SYD, Tey HL
    Response to: "Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases": Vesicular eruption in COVID-19 - to exclude varicella.
    Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19347.
    >> Share


  495. Five common skin manifestations of COVID-19 identified.
    Br J Dermatol. 2020;183:e16.
    >> Share


  496. Identificadas las principales manifestaciones en la piel de la COVID-19.
    Br J Dermatol. 2020;183:e17.
    >> Share

  497. DOIRON P
    Topical condyloma treatment: comparative evidence for a common problem.
    Br J Dermatol. 2020;183:5-6.
    >> Share

  498. ACHARYA P, Mathur M
    Low-dose naltrexone in Hailey-Hailey disease: the importance of dosing.
    Br J Dermatol. 2020;183:193.
    >> Share

  499. SHEN MX, Chen X
    Minimally important change: approach to interpretation of patient-reported outcomes.
    Br J Dermatol. 2020;183:8-9.
    >> Share

    June 2020
  500. WARREN RB, Blauvelt A, Poulin Y, Beeck S, et al
    Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial.
    Br J Dermatol. 2020 Jun 28. doi: 10.1111/bjd.19341.
    >> Share

  501. LEE JYW, McGrath JA
    Mutations in genes encoding desmosomal proteins: spectrum of cutaneous and extracutaneous abnormalities.
    Br J Dermatol. 2020 Jun 27. doi: 10.1111/bjd.19342.
    >> Share

  502. MERAD Y, Behague L, Valot S, Basmaciyan L, et al
    Epigastric cutaneous discharge: think amoebiasis.
    Br J Dermatol. 2020 Jun 25. doi: 10.1111/bjd.19246.
    >> Share

  503. GALVAN-CASAS C, Catala A, Carretero Hernandez G, Garcia-Doval I, et al
    Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from authors.
    Br J Dermatol. 2020 Jun 22. doi: 10.1111/bjd.19317.
    >> Share

  504. FERNANDEZ AP
    QuantiFERON TB-gold conversion is not uncommon in psoriasis patients under anti-TNF-alpha: reply from author.
    Br J Dermatol. 2020 Jun 22. doi: 10.1111/bjd.19316.
    >> Share

  505. DE BRUIN-WELLER M
    Systemic treatment in atopic dermatitis after 2018: from experienced-based treatment to evidence-based treatment?
    Br J Dermatol. 2020 Jun 21. doi: 10.1111/bjd.19227.
    >> Share

  506. MAHIL SK, Ezejimofor MC, Exton LS, Manounah L, et al
    Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.
    Br J Dermatol. 2020 Jun 20. doi: 10.1111/bjd.19325.
    >> Share

  507. GHADIRI SJ, Brennan P, Calonje E, Carmichael AJ, et al
    Co-inheritance of Naevoid Basal Cell Carcinoma Syndrome and Neurofibromatosis Type 1 associated with an exceptional spectrum of tumours.
    Br J Dermatol. 2020 Jun 20. doi: 10.1111/bjd.19324.
    >> Share

  508. VERHAGE EJ, Nelemans PJ, van Kuijk SMJ, Christiaans MHL, et al
    External validation of a model to predict risk of keratinocyte skin cancer after a renal transplantation in a Western European cohort.
    Br J Dermatol. 2020 Jun 20. doi: 10.1111/bjd.19326.
    >> Share

  509. GALVAN CASAS C, Catala A, Carretero Hernandez G, Garcia-Doval I, et al
    SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from the authors.
    Br J Dermatol. 2020 Jun 17. doi: 10.1111/bjd.19321.
    >> Share

  510. OOSTERHAVEN JAF
    How to measure itch in atopic dermatitis?
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19225.
    >> Share

  511. NALDI L
    Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemic.
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19190.
    >> Share

  512. HOLLESTEIN LM, Nijsten T
    Survival is excellent for most patients with thin melanoma, but patients may die from thin melanoma.
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19208.
    >> Share

  513. DRAGO F, Ciccarese G, Rebora A, Muzic SI, et al
    Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations.
    Br J Dermatol. 2020 Jun 13. doi: 10.1111/bjd.19311.
    >> Share

  514. MEGNA M, Ruggiero A, Ferrillo M, Fabbrocini G, et al
    QuantiFERON TB-gold conversion is not uncommon in psoriasis patients under anti-TNF-alpha.
    Br J Dermatol. 2020 Jun 12. doi: 10.1111/bjd.19310.
    >> Share

  515. BLAUVELT A, Paul C, van de Kerkhof P, Warren RB, et al
    Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomised, Placebo-Controlled Studies.
    Br J Dermatol. 2020 Jun 12. doi: 10.1111/bjd.19314.
    >> Share

  516. VEYSEY E
    Biologics for psoriasis: what does drug survival tell us?
    Br J Dermatol. 2020 Jun 10. doi: 10.1111/bjd.19189.
    >> Share

  517. JARRETT P
    What are the barriers to physical activity in patients with chronic plaque psoriasis?
    Br J Dermatol. 2020 Jun 10. doi: 10.1111/bjd.19209.
    >> Share

  518. OLSEN CM
    Global trends in melanoma mortality differ by sex and age.
    Br J Dermatol. 2020 Jun 8. doi: 10.1111/bjd.19166.
    >> Share

  519. BRUINS FM, Bronckers IMGJ, Cai R, Groenewoud HMM, et al
    Treatment persistence in paediatric and adolescent psoriasis patients followed into young adulthood: from topical to systemic treatment - a prospective, longitudinal, observational cohort study of 448 patients.
    Br J Dermatol. 2020 Jun 8. doi: 10.1111/bjd.19301.
    >> Share

  520. BHAT TS, Herbosa CM, Rosenberg AR, Sogade O, et al
    Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.
    Br J Dermatol. 2020 Jun 8. doi: 10.1111/bjd.19298.
    >> Share

  521. MANRIQUE-SILVA E, Rachakonda S, Millan-Esteban D, Garcia-Casado Z, et al
    Clinical, environmental, and histological distribution of BRAF, NRAS and TERT promoter mutations among cutaneous melanoma patients. A retrospective study of 563 patients.
    Br J Dermatol. 2020 Jun 7. doi: 10.1111/bjd.19297.
    >> Share

  522. EARNSHAW CH, Hunter HJA, McMullen E, Griffiths CEM, et al
    Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.
    Br J Dermatol. 2020 Jun 4. doi: 10.1111/bjd.19267.
    >> Share

  523. MARZANO AV, Cassano N, Genovese G, Moltrasio C, et al
    Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19264.
    >> Share

  524. QUAGLINO P, Prince HM, Cowan R, Vermeer M, et al
    Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study).
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19252.
    >> Share

  525. CARUGNO A, Sena P, Raponi F, Robustelli Test E, et al
    Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19266.
    >> Share

  526. REICH K, Sullivan J, Arenberger P, Jazayeri S, et al
    Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19262.
    >> Share

  527. NOUSBECK J, McAleer MA, Hurault G, Kenny E, et al
    miRNA analysis of Childhood Atopic Dermatitis reveals a role for miR-451a.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19254.
    >> Share

  528. WOLLENBERG A, Beck LA, Blauvelt A, Simpson EL, et al
    Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.
    Br J Dermatol. 2020;182:e186-e209.
    >> Share

  529. TAO J, Song Z, Yang L, Huang C, et al
    Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department.
    Br J Dermatol. 2020;182:1477-1478.
    >> Share

  530. VAN ZUUREN EJ, Arents BWM, Flohr C, Ingram JR, et al
    Publication of national dermatology guidelines as a Research Letter in the BJD: can less ever be enough?
    Br J Dermatol. 2020;182:1319-1320.
    >> Share

  531. FIFE K
    Hedgehog pathway inhibitors come of age.
    Br J Dermatol. 2020;182:1322-1323.
    >> Share

  532. WEISS JM
    Osteopontin regulatory functions in the hair follicle open a therapeutic approach for hypertrichosis.
    Br J Dermatol. 2020;182:1324-1325.
    >> Share

  533. LAIMER M
    Growth profile and anaemia in children with epidermolysis bullosa.
    Br J Dermatol. 2020;182:1327-1328.
    >> Share

  534. WEHNER MR
    Comparing the efficacy of field treatments for actinic keratosis: a critical appraisal of a randomized trial in the New England Journal of Medicine.
    Br J Dermatol. 2020;182:1343-1344.
    >> Share

  535. BELLON N, Hadj-Rabia S, Moulin F, Lambe C, et al
    The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations.
    Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19265.
    >> Share

    May 2020
  536. JANDA M, Swetter SM, Horsham C, Soyer HP, et al
    Virtual melanoma checks during a pandemic.
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19255.
    >> Share

  537. GOODRUM CA, Leighton PA, Simpson RC
    Outcome domains in Lichen Sclerosus.
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19253.
    >> Share

  538. LESTER JC, Jia JL, Zhang L, Okoye GA, et al
    Absence of Skin of Colour Images in Publications of COVID-19 Skin Manifestations.
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19258.
    >> Share

  539. HARDMAN-SMART JA, Purba TS, Panicker S, Farjo B, et al
    Does mitochondrial dysfunction of hair follicle epithelial stem cells play a role in the pathobiology of lichen planopilaris?
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19259.
    >> Share

  540. HUGHES M, Rogers S, Lepri G, Bruni C, et al
    Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
    Br J Dermatol. 2020 May 27. doi: 10.1111/bjd.19243.
    >> Share

  541. AFACH S, Chaimani A, Evrenoglou T, Penso L, et al
    Meta-analysis results do not reflect the real safety of biologics in psoriasis.
    Br J Dermatol. 2020 May 23. doi: 10.1111/bjd.19244.
    >> Share

  542. SULAIMANI J, Cluxton D, Clowry J, Petrasca A, et al
    Dimethyl fumarate modulates the Treg:Th17 cell axis in psoriasis patients.
    Br J Dermatol. 2020 May 21. doi: 10.1111/bjd.19229.
    >> Share

  543. GAMBICHLER T, Steuke AK, Schmitz L, Stockfleth E, et al
    Altered hydroxymethylation in cutaneous squamous cell carcinoma and keratoacanthoma.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19219.
    >> Share

  544. MARRA E, van Rijsingen MCJ, Alkemade JAC, Groenewoud JMM, et al
    The effect of a dermato-oncologic training program on the diagnostic skills and quality of referrals for suspicious skin lesions by general practitioners.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19214.
    >> Share

  545. WAN MT, Takeshita J
    Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis: a critical appraisal.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19216.
    >> Share

  546. BEHBAHANI S, Malerba S, Samie FH
    Acral Lentiginous Melanoma: Clinicopathologic Characteristics and Survival Outcomes in the United States National Cancer Database 2004 -2016.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19211.
    >> Share

  547. LLAMAS-VELASCO M, Munoz-Hernandez P, Lazaro-Gonzalez J, Reolid-Perez A, et al
    Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19222.
    >> Share

  548. DANGIEN A, Ram-Wolff C, Brice P, Battistella M, et al
    Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19220.
    >> Share

  549. BURGER B, Ghosh A, Ng CKY, Piscuoglio S, et al
    Discovery of heterozygous KRT10 alterations in MAUIE patients underlines the importance of regular skin cancer screening in ichthyosis with confetti-patients.
    Br J Dermatol. 2020 May 14. doi: 10.1111/bjd.19218.
    >> Share

  550. REN F, Bai X, Elston DM
    Erythroderma in a newborn infant suggesting Omenn syndrome.
    Br J Dermatol. 2020 May 12. doi: 10.1111/bjd.19138.
    >> Share

  551. MITRI F, Haenssle H, Enk A, Toberer F, et al
    Congenital multiple clustered dermatofibroma on the abdomen.
    Br J Dermatol. 2020 May 10. doi: 10.1111/bjd.19139.
    >> Share

  552. TALAGANIS JA, Gregoriou S, Stratigos AJ
    Stress and melanoma. Myth or reality?
    Br J Dermatol. 2020 May 10. doi: 10.1111/bjd.19035.
    >> Share

  553. TAKESHITA J
    Taking aim at identifying treatment targets for psoriasis.
    Br J Dermatol. 2020;182:1075-1076.
    >> Share

  554. RUTTER KJ, Ashraf I, Cordingley L, Rhodes LE, et al
    A review of studies looking at quality of life and psychological impact in people with photodermatoses - skin diseases triggered by sunlight.
    Br J Dermatol. 2020;182:e161-e182.
    >> Share

  555. ISKANDAR IYK, Parisi R, Griffiths CEM, Ashcroft DM, et al
    Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender.
    Br J Dermatol. 2020 May 1. doi: 10.1111/bjd.19169.
    >> Share

  556. SCORER M, Setterfield JF, Harman KE
    Rituximab with prednisolone as first-line treatment in pemphigus vulgaris.
    Br J Dermatol. 2020;182:1078-1079.
    >> Share

  557. WALBURN J, Sarkany RPE
    Quality of life in the photodermatoses: the hidden toll of photosensitivity.
    Br J Dermatol. 2020;182:1077.
    >> Share

  558. THORNTON MJ
    Shedding more light on photoageing.
    Br J Dermatol. 2020;182:1086-1087.
    >> Share

  559. VAN LAARHOVEN AIM, Holle H
    Optimizing audiovisual itch induction: the role of attention and expectancy.
    Br J Dermatol. 2020;182:1088-1089.
    >> Share

  560. ELEWSKI B
    Rosacea treatment: a patient-centric approach.
    Br J Dermatol. 2020;182:1090-1091.
    >> Share

  561. STROWD LC, Feldman SR
    A hands-off approach may be more successful in treating chronic hand eczema.
    Br J Dermatol. 2020;182:1078.
    >> Share

  562. BASHYAM AM, Feldman SR
    Dermatology Life Quality Index: does improving the instrument make it better?
    Br J Dermatol. 2020;182:1082-1083.
    >> Share

  563. ARDELEANU M, Shumel B, Rossi AB, Graham NMH, et al
    Response to R. Waldman et al.: 'Does IL-4 inhibition play a role in dupilumab-associated conjunctivitis?'
    Br J Dermatol. 2020;182:1310-1312.
    >> Share

    April 2020
  564. AHOUACH B, Harant S, Ullmer A, Martres P, et al
    Cutaneous lesions in a patient with COVID-19: are they related?
    Br J Dermatol. 2020 Apr 30. doi: 10.1111/bjd.19168.
    >> Share

  565. VALLERAND IA, Lewinson RT, Parsons LM, Lowerison MW, et al
    Depression as a risk factor for the development of psoriasis: a retrospective cohort study in the United Kingdom.
    Br J Dermatol. 2020 Apr 30. doi: 10.1111/bjd.19160.
    >> Share

  566. MAHIL SK, Yiu ZZN, Mason KJ, Dand N, et al
    Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19161.
    >> Share

  567. SILVERBERG JI, Lei D, Yousaf M, Janmohamed SR, et al
    Measurement properties of the Rajka-Langeland severity score in children and adults with atopic dermatitis.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19159.
    >> Share

  568. EL-CHAMI C, Foster AR, Johnson C, Clausen RP, et al
    Organic osmolytes increase expression of specific tight junction proteins in skin and alter barrier function in keratinocytes.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19162.
    >> Share

  569. GALVAN CASAS C, Catala A, Carretero Hernandez G, Rodriguez-Jimenez P, et al
    Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
    Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19163.
    >> Share

  570. GISONDI P, Facheris P, Dapavo P, Piaserico S, et al
    The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience.
    Br J Dermatol. 2020 Apr 28. doi: 10.1111/bjd.19158.
    >> Share

  571. PANDEYA N
    Rising incidence of basal cell carcinoma in women in Iceland: is it sunbed use?
    Br J Dermatol. 2020 Apr 27. doi: 10.1111/bjd.19114.
    >> Share

  572. LIN Z, Niu Y, Jiang Y, Chen B, et al
    Protective effects of dietary fish-oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: A pilot randomised, double-blind, placebo-controlled trial.
    Br J Dermatol. 2020 Apr 25. doi: 10.1111/bjd.19156.
    >> Share

  573. VON KOBYLETZKI LB
    Partner bereavement can increase the incidence of atopic dermatitis but has no effect on psoriasis.
    Br J Dermatol. 2020 Apr 22. doi: 10.1111/bjd.19046.
    >> Share

  574. JACHIET M, Bieuvelet S, Argoud AL, Vallee M, et al
    Sleep disturbance in atopic dermatitis: a case-control study using actigraphy and smartphone-collected questionnaires.
    Br J Dermatol. 2020 Apr 22. doi: 10.1111/bjd.19058.
    >> Share

  575. PALLER AS, Seyger MMB, Magarinos GA, Bagel J, et al
    Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Paediatric Patients with Moderate-to-Severe Plaque Psoriasis (IXORA-PEDS).
    Br J Dermatol. 2020 Apr 21. doi: 10.1111/bjd.19147.
    >> Share

  576. MURDOCH ME
    Mapping the burden of onchocercal skin disease.
    Br J Dermatol. 2020 Apr 17. doi: 10.1111/bjd.19143.
    >> Share

  577. ZOMORODI N, Butt M, Maczuga S, Marks J, et al
    Cost and Diagnostic Characteristics of Toxicodendron Dermatitis in the United States: A retrospective cross-sectional analysis.
    Br J Dermatol. 2020 Apr 15. doi: 10.1111/bjd.19130.
    >> Share

  578. HIBLER BP, Markova A
    Treatment of severe cutaneous adverse reaction with tocilizumab.
    Br J Dermatol. 2020 Apr 14. doi: 10.1111/bjd.19129.
    >> Share

  579. PAPP K, Menter A, Leonardi C, Soung J, et al
    Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomised phase 3 trial (AMAGINE-1).
    Br J Dermatol. 2020 Apr 14. doi: 10.1111/bjd.19132.
    >> Share

  580. VEYSEY E
    Choosing a biologic for psoriasis: is it a sprint or a marathon?
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19038.
    >> Share

  581. LOTZ M, Budden T, Furney SJ, Viros A, et al
    Molecular subtype, biological sex and age shape melanoma tumour evolution.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19128.
    >> Share

  582. PORTELLI F, Galli F, Cattaneo L, Cossa M, et al
    The prognostic impact of the extent of ulceration in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI).
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19120.
    >> Share

  583. ROLLS S, Owen E, Bertram CG, Bourke JF, et al
    What's in? What's out? Updating the British Society for Cutaneous Allergy Facial Series.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19127.
    >> Share

  584. BASU P, Tong Y, Hinds BR, Schneider JA, et al
    Nivolumab-induced toxic epidermal necrolysis with retiform purpura.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19031.
    >> Share

  585. DIZDAREVIC A, Troensegaard W, Uldahl A, Bergendorff O, et al
    Intervention Study to Evaluate the Importance of Information Given to Patients with Contact Allergy. A randomized, investigator-blinded clinical trial.
    Br J Dermatol. 2020 Apr 13. doi: 10.1111/bjd.19119.
    >> Share

  586. ELEFTHERIADOU V, Roche L, Bourke JF, Buckley DA, et al
    Allergic contact dermatitis to non-methacrylate nail allergens in the UK.
    Br J Dermatol. 2020 Apr 10. doi: 10.1111/bjd.19116.
    >> Share

  587. DORR MM, Guignard R, Auger FA, Rochette PJ, et al
    The use of tissue-engineered skin to demonstrate the negative effect of CXCL5 on epidermal UV radiation-induced CPD repair efficiency.
    Br J Dermatol. 2020 Apr 9. doi: 10.1111/bjd.19117.
    >> Share

  588. MUTHIAH S, Polubothu S, Husain A, Oliphant T, et al
    A mosaic variant in MAP2K1 is associated with giant naevus-spilus type congenital melanocytic naevus and melanoma development.
    Br J Dermatol. 2020 Apr 9. doi: 10.1111/bjd.19118.
    >> Share

  589. AFRA TP, Namitha R, Khader A, Bishnoi A, et al
    Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: erythrocyanotic vascular patches associated with an underlying rib plasmacytoma.
    Br J Dermatol. 2020 Apr 9. doi: 10.1111/bjd.19037.
    >> Share

  590. LIN P, Zhu S, Huang Y, Li L, et al
    Adverse Skin Reactions Among Healthcare Workers During the Coronavirus Disease 2019 Outbreak: A Survey in Wuhan and Its Surrounding Regions.
    Br J Dermatol. 2020 Apr 7. doi: 10.1111/bjd.19089.
    >> Share

  591. RAJAN MB, Budania A, Vishwajeet V
    Drawstring papules in an Indian woman.
    Br J Dermatol. 2020 Apr 6. doi: 10.1111/bjd.19032.
    >> Share

  592. KIM MS, Lee S, Park SB, Kim KY, et al
    Magnolol induces adipogenic differentiation in human skin.
    Br J Dermatol. 2020 Apr 5. doi: 10.1111/bjd.19063.
    >> Share


  593. Revolutionizing Atopic Dermatitis, 5 April 2020.
    Br J Dermatol. 2020 Apr 3. doi: 10.1111/bjd.19043.
    >> Share

  594. CUST AE
    Gene-environment interactions and melanoma risk.
    Br J Dermatol. 2020 Apr 1. doi: 10.1111/bjd.18986.
    >> Share

  595. FERRIS LK
    Skin cancer screening: it's a matter of time.
    Br J Dermatol. 2020 Apr 1. doi: 10.1111/bjd.18974.
    >> Share

  596. THOMPSON AR, Cockayne S
    It's the worry that got him in the end: the importance in treating melanoma holistically and dealing with fear of recurrence.
    Br J Dermatol. 2020;182:821-822.
    >> Share

  597. SBIDIAN E, Le Cleach L
    'COre SUBgroup SETs (COSUBSET)' initiative is needed.
    Br J Dermatol. 2020;182:824-825.
    >> Share

  598. WEHNER MR
    WHO can decrease indoor tanning?
    Br J Dermatol. 2020;182:824.
    >> Share

  599. UTER W
    Patient recall may be of limited use in establishing the clinical relevance of positive patch test reactions (to fragrances).
    Br J Dermatol. 2020;182:831-832.
    >> Share

  600. LUDWIG RJ
    Tissue-specific personalized medicine: the next level of individualized treatment.
    Br J Dermatol. 2020;182:833-834.
    >> Share

  601. LACARRUBBA F, Verzi AE, Musumeci ML, Micali G, et al
    High capillary diameter in psoriatic plaques of the lower legs.
    Br J Dermatol. 2020;182:1064-1065.
    >> Share

  602. NICHOLSON LT, Haemel A
    Outcome measures in dermatomyositis: quality of life and the patient perspective.
    Br J Dermatol. 2020;182:830-831.
    >> Share

  603. COLEBUNDERS R, Wafula ST, Hotterbeekx A, Siewe-Fodjo JN, et al
    Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programmes.
    Br J Dermatol. 2020;182:1064.
    >> Share

  604. HOWELLS L
    Knowing the score - it's not quite enough anymore.
    Br J Dermatol. 2020;182:828-829.
    >> Share

  605. WALKER SL
    New therapeutics for leprosy.
    Br J Dermatol. 2020;182:837-838.
    >> Share

  606. O'SHAUGHNESSY RFL
    Understanding actinic keratosis to reduce squamous cell carcinoma incidence.
    Br J Dermatol. 2020;182:834-835.
    >> Share

  607. KOVACS D, Hegyi K, Szegedi A, Deak D, et al
    Isotretinoin is indirectly effective in sebocytes.
    Br J Dermatol. 2020;182:1052-1054.
    >> Share

  608. FREW JW
    Putting nodule counts behind us: hidradenitis suppurativa outcome measures independent of descriptive semantics.
    Br J Dermatol. 2020;182:829-830.
    >> Share

    March 2020
  609. BRANS R
    Hand dermatitis in nurses: is promotion of protective behaviour ineffective?
    Br J Dermatol. 2020 Mar 30. doi: 10.1111/bjd.18973.
    >> Share

  610. YANG L, Zhang T, Zhang C, Xiao C, et al
    Upregulated E3 ligase Trim21 in psoriatic epidermis ubiquitylates NF-kappaB p65 subunit and promotes inflammation in keratinocytes.
    Br J Dermatol. 2020 Mar 30. doi: 10.1111/bjd.19057.
    >> Share

  611. FREDEAU L, Bohelay G, Shourick J, Piver D, et al
    Paraneoplastic neutrophilic leukemoid reaction in a melanoma patient: association between tumour volume and leukocytosis.
    Br J Dermatol. 2020 Mar 30. doi: 10.1111/bjd.19059.
    >> Share

  612. TRUONG A, Secrest AM, Fino NF, Laggis CW, et al
    Homeless status and associations with treatment disparities for common skin conditions.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19051.
    >> Share

  613. YIU ZZN, Parisi R, Lunt M, Warren RB, et al
    Risk of Hospitalisation and Death due to Infection in People with Psoriasis: a Population-based Cohort Study using the Clinical Practice Research Datalink.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19052.
    >> Share

  614. STAUGHTON RCD, Bridgett CK, Noren P, Goulding JMR, et al
    Habitual scratching amplifies and perpetuates atopic dermatitis.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19049.
    >> Share

  615. ROBINSON JK, Abou-El-Seoud D, Reavy R, Turrisi R, et al
    Persistence of partner-assisted skin self-examination supported by "being in this together": a randomized trial.
    Br J Dermatol. 2020 Mar 28. doi: 10.1111/bjd.19048.
    >> Share

  616. ROBERT J, Tavernier E, Boccara O, Mashiah J, et al
    Modalities of use of oral propranolol in proliferative infantile hemangiomas: an international survey among practitioners.
    Br J Dermatol. 2020 Mar 27. doi: 10.1111/bjd.19047.
    >> Share

  617. FUJISAWA Y, Fujimura T, Matsushita S, Yamamoto Y, et al
    The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multi-center, prospective, observational study.
    Br J Dermatol. 2020 Mar 20. doi: 10.1111/bjd.19042.
    >> Share

  618. BEDAIR K, Elhadad A, Hamad S, Ferguson J, et al
    No association between whole-body UVA1 phototherapy and skin cancers in humans: a cancer registry linkage study.
    Br J Dermatol. 2020 Mar 20. doi: 10.1111/bjd.19041.
    >> Share

  619. KINOSHITA-ISE M
    Lichen planopilaris and frontal fibrosing alopecia: branches from the same tree bear different fruits.
    Br J Dermatol. 2020 Mar 20. doi: 10.1111/bjd.18972.
    >> Share

  620. SMITH CH, Yiu ZZ, Bale T, Burden AD, et al
    British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020 - a rapid update.
    Br J Dermatol. 2020 Mar 18. doi: 10.1111/bjd.19039.
    >> Share

  621. PHILIPP S, Menter A, Nikkels AF, Barber K, et al
    Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients (>/=6 to <12 years of age): efficacy, safety, pharmacokinetic, and biomarker results from the open-label CADMUS Jr study.
    Br J Dermatol. 2020 Mar 16. doi: 10.1111/bjd.19018.
    >> Share

  622. JUNEJO MH, Kentley J, Rajpopat M, Tan XL, et al
    Therapeutic options for erosive pustular dermatosis of the scalp: a systematic review.
    Br J Dermatol. 2020 Mar 12. doi: 10.1111/bjd.19026.
    >> Share

  623. YEN H, Yen H, Chi CC
    Is psoriasis associated with dementia or cognitive impairment? A Critically Appraised Topic.
    Br J Dermatol. 2020 Mar 11. doi: 10.1111/bjd.19025.
    >> Share

  624. SCHNEEWEISS MC, Perez-Chada L, Gottlieb AB, Merola J, et al
    Older adults on systemic treatment for psoriasis and risk of infection: a propensity score matched population-based study.
    Br J Dermatol. 2020 Mar 11. doi: 10.1111/bjd.19028.
    >> Share

  625. MAJEED-ARISS R, McPhee M, McAteer H, Griffiths CEM, et al
    "Mind the gap": What patients and clinicians believe is "unknown" about psoriasis.
    Br J Dermatol. 2020 Mar 9. doi: 10.1111/bjd.19023.
    >> Share

  626. OLAMIJU B, Leventhal JS
    Near total body vitiligo secondary to immunotherapy for metastatic melanoma.
    Br J Dermatol. 2020 Mar 9. doi: 10.1111/bjd.18944.
    >> Share

  627. PARK YM, Seo SJ
    Evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis is currently lacking.
    Br J Dermatol. 2020 Mar 5. doi: 10.1111/bjd.18895.
    >> Share

  628. VON SCHUCKMANN LA, Khosrotehrani K, Ghiasvand R, Hughes MCB, et al
    Statins may reduce disease recurrence in patients with ulcerated primary melanoma.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19012.
    >> Share

  629. GISONDI P, Virga C, Piaserico S, Meneguzzo A, et al
    Switching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19013.
    >> Share

  630. ISAKSSON K, Mikiver R, Eriksson H, Lapins J, et al
    Survival in 31 670 patients with thin melanomas - a Swedish population-based study.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19015.
    >> Share

  631. YANG DD, Salciccioli JD, Marshall DC, Sheri A, et al
    Trends in malignant melanoma mortality in 31 countries from 1985 to 2015.
    Br J Dermatol. 2020 Mar 4. doi: 10.1111/bjd.19010.
    >> Share

  632. WONG AYS, Froslev T, Dearing L, Forbes HJ, et al
    The association between partner bereavement and melanoma: cohort studies in the U.K. and Denmark.
    Br J Dermatol. 2020 Mar 3. doi: 10.1111/bjd.18889.
    >> Share

  633. YIU ZZN, Mason KJ, Hampton PJ, Reynolds NJ, et al
    Drug Survival of Adalimumab, Ustekinumab, and Secukinumab in Patients with Psoriasis: a Prospective Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18981.
    >> Share

  634. GOLLINS C, Shah A, Sinha K, Khan S, et al
    Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK.
    Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18982.
    >> Share

  635. HARADA K, Irisawa R, Ito T, Uchiyama M, et al
    The effectiveness of dupilumab in alopecia areata patients with atopic dermatitis: a case series of seven patients.
    Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18976.
    >> Share

  636. STEELE L, O'Toole EA
    Pachyonychia congenita, a paradigm for rare skin disorders.
    Br J Dermatol. 2020;182:521-522.
    >> Share

  637. INGRAM J
    Editor's Choice: rare skin diseases themed issue.
    Br J Dermatol. 2020;182:ix.
    >> Share

  638. OGDIE A, Eder L
    The need for strategies to address obesity and psoriatic arthritis prevention in psoriasis.
    Br J Dermatol. 2020;182:523-524.
    >> Share

  639. MORDAUNT DA
    Sharing (data) is caring for patients with pachyonychia congenita.
    Br J Dermatol. 2020;182:537.
    >> Share

  640. YOUSSEFIAN L, Vahidnezhad H
    Management of symptomatic mucosal involvement in paediatric pachyonychia congenita.
    Br J Dermatol. 2020;182:536-537.
    >> Share

  641. THOMAS BR, Sahota A
    Pachyonychia congenita and botulinum toxin.
    Br J Dermatol. 2020;182:531-532.
    >> Share

  642. LEUBE RE, Schwarz N
    Current mysteries of pachyonychia congenita.
    Br J Dermatol. 2020;182:525-526.
    >> Share

  643. MATE K
    Itching for the right treatment.
    Br J Dermatol. 2020;182:541.
    >> Share

  644. MOSS C
    Podiatrists gaining a foothold.
    Br J Dermatol. 2020;182:527-528.
    >> Share

  645. NELSON PA
    Good practice in dermatological patient-reported outcome measure development: an example from localized scleroderma.
    Br J Dermatol. 2020;182:529.
    >> Share

  646. VETTER A, Magin TM
    Old mitochondria accumulate in pachyonychia congenita.
    Br J Dermatol. 2020;182:529-530.
    >> Share

  647. MAGLIE R, Hertl M
    Improving the diagnosis of autoimmune blistering dermatoses of the oral mucosa.
    Br J Dermatol. 2020;182:539-540.
    >> Share

  648. UITTO J
    Epidermolysis bullosa: diagnostic guidelines in the laboratory setting.
    Br J Dermatol. 2020;182:526-527.
    >> Share

  649. HAUSSER I
    Diagnosis of Ehlers-Danlos syndrome: data deficiency still does not allow establishment of a complete history of the disease and its pathomechanisms.
    Br J Dermatol. 2020;182:535-536.
    >> Share

  650. DAMIANI G
    Apremilast does not appear to outlast methotrexate.
    Br J Dermatol. 2020;182:534-535.
    >> Share

    February 2020
  651. JUNG F, Sibbald C, Bohdanowicz M, Ingram JR, et al
    Systematic Review of Efficacies and Adverse Effects of Treatments for Pityriasis Lichenoides.
    Br J Dermatol. 2020 Feb 28. doi: 10.1111/bjd.18977.
    >> Share

  652. AUKER L, Cordingley L, Pye DR, Griffiths CEM, et al
    What are the barriers to physical activity in patients with chronic plaque psoriasis?
    Br J Dermatol. 2020 Feb 27. doi: 10.1111/bjd.18979.
    >> Share

  653. SILVERBERG JI, Lai JS, Patel K, Singam V, et al
    Measurement properties of the PROMIS Itch Questionnaire - itch severity assessments in adults with atopic dermatitis.
    Br J Dermatol. 2020 Feb 27. doi: 10.1111/bjd.18978.
    >> Share

  654. UTER W, Gefeller O, Mahler V, Geier J, et al
    Trends and current spectrum of contact allergy in Central Europe: Results of the Information Network of Departments of Dermatology (IVDK), 2007 - 2018.
    Br J Dermatol. 2020 Feb 27. doi: 10.1111/bjd.18946.
    >> Share

  655. PROBY CM, Harwood CA
    Skin cancer burden in lung transplant recipients: we need to do better!
    Br J Dermatol. 2020 Feb 25. doi: 10.1111/bjd.18903.
    >> Share

  656. CHI CC
    Dermoscopy and reflectance confocal microscopy for early diagnosis of amelanotic/hypomelanotic melanoma: still a long way to go?
    Br J Dermatol. 2020 Feb 23. doi: 10.1111/bjd.18893.
    >> Share

  657. TAYLOR N
    Mercury exposure and nonmelanoma skin cancer: what're the odds?
    Br J Dermatol. 2020 Feb 23. doi: 10.1111/bjd.18919.
    >> Share

  658. HALLING AS, Bager P, Skov L, Zachariae C, et al
    The interaction between filaggrin mutations and hard domestic water on the risk of early-onset atopic dermatitis.
    Br J Dermatol. 2020 Feb 21. doi: 10.1111/bjd.18965.
    >> Share

  659. SENCHYNA A, Simon S, Cisse H, Ginouves M, et al
    American Cutaneous Leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate.
    Br J Dermatol. 2020 Feb 20. doi: 10.1111/bjd.18964.
    >> Share

  660. CHOONG CK, Merola JF, Han J, Li X, et al
    Indoor tanning use is associated with psoriasis from the Nurses' Health Study II.
    Br J Dermatol. 2020 Feb 20. doi: 10.1111/bjd.18963.
    >> Share

  661. HWANG S, Johnson A, Fabbro S, Hastings J, et al
    Topical imiquimod monotherapy for indolent primary cutaneous B-cell lymphomas (PCBCL): a single-institution experience.
    Br J Dermatol. 2020 Feb 20. doi: 10.1111/bjd.18961.
    >> Share

  662. YOULDEN DR, Baade PD
    Ongoing cancer burden after a diagnosis of cutaneous squamous cell carcinoma.
    Br J Dermatol. 2020 Feb 19. doi: 10.1111/bjd.18900.
    >> Share

  663. STEEB T, Wessely A, Heppt F, Harlass M, et al
    Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of existing evidence.
    Br J Dermatol. 2020 Feb 18. doi: 10.1111/bjd.18957.
    >> Share

  664. LIVINGSTONE E, Zaremba A, Horn S, Ugurel S, et al
    GNAQ and GNA11 mutant non-uveal melanoma, a subtype distinct from both cutaneous and uveal melanoma.
    Br J Dermatol. 2020 Feb 16. doi: 10.1111/bjd.18947.
    >> Share

  665. CHAMBRELAN E, Barbarot S, Bekel L, Poizeau F, et al
    Drug survival and post-drug survival of systemic treatments in a national French cohort of children with atopic dermatitis.
    Br J Dermatol. 2020 Feb 9. doi: 10.1111/bjd.18941.
    >> Share

  666. ABJI F, Lee K, Math M, Pollock RA, et al
    Declining levels of serum CXCL10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: A new biomarker?
    Br J Dermatol. 2020 Feb 9. doi: 10.1111/bjd.18940.
    >> Share

  667. KIBBI N, Rajan N
    Reading through genetic 'stop signs': a therapeutic strategy in genetic skin disease.
    Br J Dermatol. 2020 Feb 9. doi: 10.1111/bjd.18870.
    >> Share

  668. PRICE KN, Krase JM, Loh TY, Hsiao JL, et al
    Racial and Ethnic Disparities in Global Atopic Dermatitis Clinical Trials.
    Br J Dermatol. 2020 Feb 7. doi: 10.1111/bjd.18938.
    >> Share

  669. ADALSTEINSSON JA, Ratner D, Olafsdottir E, Grant-Kels J, et al
    Basal cell carcinoma: an emerging epidemic in women in Iceland.
    Br J Dermatol. 2020 Feb 7. doi: 10.1111/bjd.18937.
    >> Share

  670. RHEE J, Vance TM, Lim R, Christiani DC, et al
    Association of blood mercury levels with nonmelanoma skin cancer in the U.S.A. using National Health and Nutrition Examination Survey data (2003-2016).
    Br J Dermatol. 2020 Feb 5. doi: 10.1111/bjd.18797.
    >> Share

  671. FILONI A, Lospalluti L, Zanframundo G, De Marco A, et al
    Light brown structureless areas as predictor of melanoma in situ.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18926.
    >> Share

  672. CHENG BT, Silverberg JI
    Long-term and multiple hospital readmissions after discharge for Stevens-Johnson Syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18923.
    >> Share

  673. HAS C, Bauer JW, Bodemer C, Bolling M, et al
    Consensus re-classification of inherited epidermolysis bullosa and other disorders with skin fragility.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18921.
    >> Share

  674. LEI D, Yousaf M, Janmohamed SR, Vakharia PP, et al
    Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in Adults With Atopic Dermatitis.
    Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18920.
    >> Share

  675. TSAI TF
    Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment.
    Br J Dermatol. 2020 Feb 3. doi: 10.1111/bjd.18869.
    >> Share

  676. BLOME C
    Measuring what's important to adolescents with psoriasis.
    Br J Dermatol. 2020 Feb 3. doi: 10.1111/bjd.18872.
    >> Share

  677. CUST AE
    Who dies from thin melanoma?
    Br J Dermatol. 2020 Feb 3. doi: 10.1111/bjd.18871.
    >> Share

  678. NAVARRETE-DECHENT C, Marghoob AA, Chen CJ
    The road to real-time, bedside, optical imaging pathology: basal cell carcinoma and beyond.
    Br J Dermatol. 2020;182:257-259.
    >> Share

  679. POLUBOTHU S, McGuire N, Al-Olabi L, Baird W, et al
    Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
    Br J Dermatol. 2020;182:e55-e84.
    >> Share

  680. BAHADORAN P
    Dermoscopy in general dermatology: a 'Delphinitive' step forward.
    Br J Dermatol. 2020;182:260-261.
    >> Share

  681. VON KOBYLETZKI LB
    Most eczema smartphone apps do not conform to clinical guidelines.
    Br J Dermatol. 2020;182:276.
    >> Share

  682. KRIDIN K, Cohen AD
    Hidradenitis suppurativa and infections.
    Br J Dermatol. 2020;182:267.
    >> Share

  683. DELEURAN M, Vestergaard C
    Real-world evidence vs. randomized control trials.
    Br J Dermatol. 2020;182:275-276.
    >> Share

  684. HUNTER HJA
    Remember to assess the 'whole' patient: a further immune-related adverse event of programmed cell death 1 checkpoint inhibition.
    Br J Dermatol. 2020;182:276-277.
    >> Share

  685. KIRBY JS, Leiphart P
    Standing up together to the shame and stigma associated with hidradenitis suppurativa.
    Br J Dermatol. 2020;182:267-268.
    >> Share

  686. KOTTNER J
    The clinical relevance of nonblanchable erythema in pressure ulcer prevention.
    Br J Dermatol. 2020;182:262-263.
    >> Share

  687. MORITA A, Ikumi K
    Can the dose and dosing interval of biologics be optimized?
    Br J Dermatol. 2020;182:264-266.
    >> Share

  688. SLADDEN M, Zagarella S, Popescu C, Bigby M, et al
    The sentinel node biopsy has not come of age.
    Br J Dermatol. 2020;182:518.
    >> Share

  689. VAN LEE CB, Mooyaart AL, van den Bos RR
    Mohs micrographic surgery vs. standard surgical excision?: reply from authors.
    Br J Dermatol. 2020;182:517-518.
    >> Share

  690. SLATER DN
    Mohs micrographic surgery vs. standard surgical excision?
    Br J Dermatol. 2020;182:517.
    >> Share

  691. SHEARER SM, Milani-Nejad N, Kaffenberger BH
    Advances in acute exanthemas.
    Br J Dermatol. 2020;182:268-269.
    >> Share

  692. MORRIS-JONES R
    Toenail onychomycosis - it's no fungi to have around: treatment analysis to the rescue!
    Br J Dermatol. 2020;182:263.
    >> Share

  693. BILGIC A, Murrell DF
    Novel diagnostic method to differentiate antilaminin-332 pemphigoid from other forms of pemphigoid.
    Br J Dermatol. 2020;182:270-271.
    >> Share

    January 2020
  694. BUJA A, Rivera M, De Polo A, Zorzi M, et al
    Real-world data for direct stage-specific costs of melanoma healthcare.
    Br J Dermatol. 2020 Jan 29. doi: 10.1111/bjd.18896.
    >> Share

  695. SIMPSON EL, Lacour JP, Spelman L, Galimberti R, et al
    Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Topical Corticosteroids: Results from Two Randomised Monotherapy Phase 3 Trials.
    Br J Dermatol. 2020 Jan 29. doi: 10.1111/bjd.18898.
    >> Share

  696. MADAN I, Parsons V, Ntani G, Coggon D, et al
    A behaviour change package to prevent hand dermatitis in nurse working in the National Health Service: results of a cluster randomised controlled trial.
    Br J Dermatol. 2020 Jan 27. doi: 10.1111/bjd.18862.
    >> Share

  697. POLESIE S, Gillstedt M, Paoli J, Osmancevic A, et al
    Methotrexate treatment for psoriasis patients and risk of cutaneous melanoma: a nested case-control study.
    Br J Dermatol. 2020 Jan 25. doi: 10.1111/bjd.18887.
    >> Share

  698. OLABI B, Tasker F, Williams HC
    'Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial'; a critical appraisal.
    Br J Dermatol. 2020 Jan 24. doi: 10.1111/bjd.18891.
    >> Share

  699. RONCONI G, Piccinni C, Dondi L, Calabria S, et al
    Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real-world data from a large Italian database.
    Br J Dermatol. 2020 Jan 23. doi: 10.1111/bjd.18888.
    >> Share

  700. WARD SV, Gibbs DC, Orlow I, Thomas NE, et al
    Association of IRF4 SNP rs12203592 with melanoma-specific survival.
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18881.
    >> Share

  701. DARLING TN
    Mosaic forms of an autosomal dominant skin disorder.
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18847.
    >> Share

  702. FUXENCH ZCC
    Pain in atopic dermatitis: it's time we addressed this symptom further.
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18785.
    >> Share

  703. KRENGEL S
    Congenital melanocytic naevi. Who benefits from a therapy?
    Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18706.
    >> Share

  704. DAI W, Liu H, Liu Y, Xu X, et al
    Genetic variants in the folate metabolic pathway genes predict melanoma-specific survival.
    Br J Dermatol. 2020 Jan 18. doi: 10.1111/bjd.18878.
    >> Share

  705. TRETTIN B, Feldman S, Andersen F, Danbjorg DB, et al
    A changed life: The life experiences of patients with psoriasis receiving biological treatment.
    Br J Dermatol. 2020 Jan 17. doi: 10.1111/bjd.18876.
    >> Share

  706. YIU ZZN
    Repurposing existing trial data to infer relative efficacy of biologics: guselkumab vs. ustekinumab for psoriasis.
    Br J Dermatol. 2020 Jan 14. doi: 10.1111/bjd.18848.
    >> Share

  707. TOROK KS
    Assigning values to the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) score indicating degree of severity and responsiveness: fostering practical use in clinic and therapeutic studies for morphoea/localized scleroderma.
    Br J Dermatol. 2020 Jan 14. doi: 10.1111/bjd.18782.
    >> Share

  708. CHIN YPH, Hou ZY, Lee MY, Chu HM, et al
    A Patient-Oriented, General Practitioner-Level, Deep Learning-based Cutaneous Pigmented Lesion Risk Classifier on Smartphone.
    Br J Dermatol. 2020 Jan 6. doi: 10.1111/bjd.18859.
    >> Share

  709. AL-JANABI A, Warren RB
    Risankizumab versus adalimumab for moderate-to-severe plaque psoriasis: a critical appraisal.
    Br J Dermatol. 2020 Jan 3. doi: 10.1111/bjd.18856.
    >> Share

  710. CRAIG S, Viros A
    New biomarkers improve stratification of patients with melanoma.
    Br J Dermatol. 2020;182:5-6.
    >> Share

  711. GILABERTE Y
    Light-emitting textiles: an innovative and friendly way to perform photodynamic therapy.
    Br J Dermatol. 2020;182:11-12.
    >> Share

  712. NAVRAZHINA K, Frew JW
    Consensus definitions of disease activity in hidradenitis suppurativa: crossing the semantic gap.
    Br J Dermatol. 2020;182:7.
    >> Share

  713. ZENKER M
    The mosaic hedgehog spectrum: another lesson on the polymorphy of mosaicism.
    Br J Dermatol. 2020;182:22-23.
    >> Share

  714. TAN J
    Evaluating rosacea noninvasively and objectively.
    Br J Dermatol. 2020;182:10-11.
    >> Share

  715. CHANDLER DJ, Fuller LC
    Removing the mystery of mite isolation - opening up scabies diagnosis?
    Br J Dermatol. 2020;182:21-22.
    >> Share

  716. WALDMAN RA, DeWane ME, Sloan SB
    Does interleukin-4 inhibition play a role in dupilumab-associated conjunctivitis?
    Br J Dermatol. 2020;182:251.
    >> Share

  717. ALHUSAYEN R
    The pain of hidradenitis suppurativa: 'We only see what we know'.
    Br J Dermatol. 2020;182:17-18.
    >> Share

  718. OHYAMA M
    Does skewing of cytokine production link alopecia areata and depression?
    Br J Dermatol. 2020;182:15-16.
    >> Share

    December 2019
  719. BLAUVELT A, Papp K, Gottlieb A, Jarell A, et al
    A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 12-Week Efficacy, Safety, and Speed of Response from a Randomized, Double-Blinded Trial.
    Br J Dermatol. 2019 Dec 30. doi: 10.1111/bjd.18851.
    >> Share

  720. MEGNA M, Fabbrocini G
    Psoriasis and atopic dermatitis: different entities with unsolved challenges.
    Br J Dermatol. 2019 Dec 29. doi: 10.1111/bjd.18789.
    >> Share

  721. MORRIS-JONES R
    Oral ivermectin for infants and children under 15 kg appears to be a safe and effective treatment for scabies.
    Br J Dermatol. 2019 Dec 29. doi: 10.1111/bjd.18788.
    >> Share

  722. HARRIES M, Hardman J, Chaudhry I, Poblet E, et al
    Profiling the human hair follicle immune system in lichen planopilaris and frontal fibrosing alopecia: Can macrophage polarization differentiate these two conditions microscopically?
    Br J Dermatol. 2019 Dec 28. doi: 10.1111/bjd.18854.
    >> Share

  723. KEARNEY N, Gallagher C, Lally A
    Image Gallery: Neglected skin cancer in an elderly patient with cognitive impairment.
    Br J Dermatol. 2019 Dec 26. doi: 10.1111/bjd.18542.
    >> Share

  724. FERNANDEZ AP
    The skin myositis Delphi group puts the details in 'skin-predominant' dermatomyositis.
    Br J Dermatol. 2019 Dec 25. doi: 10.1111/bjd.18790.
    >> Share

  725. THOMPSON JF, Friedman EB
    The intriguing association between smoking and reduced melanoma risk.
    Br J Dermatol. 2019 Dec 23. doi: 10.1111/bjd.18728.
    >> Share

  726. WANG H, Wang X, Yang B, Liu H, et al
    Image Gallery: Onychomadesis in linear IgA bullous dermatosis.
    Br J Dermatol. 2019 Dec 22. doi: 10.1111/bjd.18744.
    >> Share

  727. HARTMAN RI, Xue Y, Singer S, Markossian TW, et al
    Modeling the Value of Risk Stratified Skin Cancer Screening of Asymptomatic Patients by Dermatologists.
    Br J Dermatol. 2019 Dec 22. doi: 10.1111/bjd.18816.
    >> Share

  728. MAURELLI M, Gisondi P, Danese E, Gelati M, et al
    Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis.
    Br J Dermatol. 2019 Dec 19. doi: 10.1111/bjd.18807.
    >> Share

  729. WAY M, Marquart L, Chambers DC, Hopkins P, et al
    Skin cancer multiplicity in lung transplant recipients: prospective, population-based study.
    Br J Dermatol. 2019 Dec 19. doi: 10.1111/bjd.18812.
    >> Share

  730. CHATTOPADHYAY S, Zheng G, Hemminki A, Forsti A, et al
    Influence of family history on risk of second primary cancers and survival in squamous cell skin cancer patients.
    Br J Dermatol. 2019 Dec 19. doi: 10.1111/bjd.18809.
    >> Share

  731. LEE HY, Creamer D
    Stevens-Johnson syndrome/toxic epidermal necrolysis: a chronic condition?
    Br J Dermatol. 2019 Dec 18. doi: 10.1111/bjd.18726.
    >> Share

  732. DOCAMPO-SIMON A, Sanchez-Pujol MJ, Belinchon-Romero I, Niveiro M, et al
    Image Gallery: Haematogenous metastasis of melanoma mimicking lymphangioma.
    Br J Dermatol. 2019 Dec 17. doi: 10.1111/bjd.18723.
    >> Share

  733. VILLACORTA R, Teeple A, Lee S, Fakharzadeh S, et al
    A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis.
    Br J Dermatol. 2019 Dec 16. doi: 10.1111/bjd.18798.
    >> Share

  734. BORRONI RG, Costanzo A
    Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis.
    Br J Dermatol. 2019 Dec 15. doi: 10.1111/bjd.18717.
    >> Share

  735. BETZ-STABLEIN B, Koh U, Plasmeijer E, Janda M, et al
    Self-reported naevus density may lead to misclassification of melanoma risk.
    Br J Dermatol. 2019 Dec 12. doi: 10.1111/bjd.18802.
    >> Share

  736. TALPUR R
    Quality of life, Skindex-29, mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2019 Dec 11. doi: 10.1111/bjd.18710.
    >> Share

  737. GESSER B, Rasmussen MK
    Psoriatic epidermis expresses high level of inflammatory mediators and the CDK2/4 cyclin-dependent kinases are involved in the regulation of cell-cycle progression in epidermal cells.
    Br J Dermatol. 2019 Dec 11. doi: 10.1111/bjd.18713.
    >> Share

  738. PUIG L
    Psoriasis Area and Severity Index vs. pharmacokinetics: can monitoring 4-week postinjection ustekinumab concentrations in patients with suboptimal response be clinically relevant?
    Br J Dermatol. 2019 Dec 11. doi: 10.1111/bjd.18709.
    >> Share

  739. SUN J, Wang Y
    KIR3DL2 in cutaneous T-cell lymphoma: from a promising biomarker to a potential therapeutic target.
    Br J Dermatol. 2019 Dec 5. doi: 10.1111/bjd.18682.
    >> Share

  740. HENDRICKS AJ, Eichenfield LF, Shi VY
    The Impact of Airborne Pollution on Atopic Dermatitis-A Literature Review.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18781.
    >> Share

  741. BLAKEWAY H, Van-de-Velde V, Allen VB, Kravvas G, et al
    What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? - A systematic review.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18778.
    >> Share

  742. MCMENIMAN EK, Duffy DL, Jagirdar K, Lee KJ, et al
    The interplay of sun-damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18777.
    >> Share

  743. LAW MH
    Making sense of different measures of skin ageing.
    Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18700.
    >> Share

  744. HART PH
    The changing transcriptome in human skin following in vivo exposure to erythemal solar-simulated ultraviolet radiation.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18683.
    >> Share

  745. TRAN B, Guffey D, Noland M
    Image Gallery: Otic lichen planus complicated by tympanic membrane rupture successfully treated with topical 1% tacrolimus.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18687.
    >> Share

  746. O'REILLY P, Kennedy C, Meskell P, Coffey A, et al
    The psychological impact of Stevens-Johnson syndrome and toxic epidermal necrolysis on patients' lives: A critically appraised topic.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18746.
    >> Share

  747. HALLING-OVERGAARD AS, Thyssen JP
    Modifiable risk factors in paediatric atopic dermatitis: is the sun finally shining?
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18690.
    >> Share

  748. KIM JH
    Personalized dosing of ixekizumab for psoriasis.
    Br J Dermatol. 2019 Dec 2. doi: 10.1111/bjd.18701.
    >> Share

  749. CHO SY, Kim AY, Kim J, Choi DH, et al
    Impact of oxytocin on skin ageing.
    Br J Dermatol. 2019;181:e148-e171.
    >> Share

    November 2019
  750. BELL KJL
    Causal inference in melanoma epidemiology using Mendelian randomization.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18646.
    >> Share

  751. WONG AYS, Froslev T, Forbes HJ, Kjaersgaard A, et al
    Partner bereavement and risk of psoriasis and atopic eczema: cohort studies in the United Kingdom and Denmark.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18740.
    >> Share

  752. EMAM S, Du AX, Surmanowicz P, Thomsen SF, et al
    Predicting the Long-term Outcomes of Biologics in Psoriasis Patients using Machine Learning.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18741.
    >> Share

  753. GOLDBERG I, Mashiah J, Kutz A, Derowe A, et al
    Symptomatic mucosal involvement in pachyonychia congenita: the challenges in infants and young children.
    Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18742.
    >> Share

  754. ROBINSON JK
    Frequency of 'regular' skin checks by dermatologists for melanoma survivors.
    Br J Dermatol. 2019 Nov 27. doi: 10.1111/bjd.18626.
    >> Share

  755. ISMAIL N, Bray N
    Atopic dermatitis: economic burden and strategies for high-quality care.
    Br J Dermatol. 2019 Nov 27. doi: 10.1111/bjd.18636.
    >> Share

  756. WEBER J, Glutsch V, Geissinger E, Haug L, et al
    Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease.
    Br J Dermatol. 2019 Nov 26. doi: 10.1111/bjd.18739.
    >> Share

  757. SIBBALD C
    Dupilumab in adolescent atopic dermatitis: interpreting the data.
    Br J Dermatol. 2019 Nov 25. doi: 10.1111/bjd.18627.
    >> Share

  758. BERGQVIST C, Mezzarobba M, Weil A, Sbidian E, et al
    Persistence of treatment with conventional systemic agents for patients with psoriasis: a real-world analysis of 73,168 new-users from the French National Health Insurance database (SNDS).
    Br J Dermatol. 2019 Nov 23. doi: 10.1111/bjd.18734.
    >> Share

  759. DE WIJS LEM, Nguyen NT, Kunkeler ACM, Nijsten T, et al
    Clinical and histopathological characterization of paradoxical head and neck erythema in atopic dermatitis patients treated with dupilumab: a case series.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18730.
    >> Share

  760. OLSEN CM, Pandeya N, Law MH, MacGregor S, et al
    Does polygenic risk influence associations between sun exposure and melanoma?: a prospective cohort analysis.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18703.
    >> Share

  761. LAN J, Wen J, Cao S, Yin T, et al
    The diagnostic accuracy of dermoscopy and reflectance confocal microscopy for amelanotic/hypomelanotic melanoma: a systematic review and meta-analysis.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18722.
    >> Share

  762. FUJIMURA T, Tanita K, Sato Y, Lyu C, et al
    Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19.
    Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18721.
    >> Share

  763. RANDA H, Khoury LR, Gronborg TK, Lomholt JJ, et al
    Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument (APso-QOL): a disease-specific measure of quality of life in adolescents with psoriasis.
    Br J Dermatol. 2019 Nov 19. doi: 10.1111/bjd.18719.
    >> Share

  764. WALSH S, Creamer D
    Shaping specialist treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Br J Dermatol. 2019 Nov 19. doi: 10.1111/bjd.18612.
    >> Share

  765. JOHANSSON P
    Differences between acral and nonacral melanoma genomes.
    Br J Dermatol. 2019 Nov 19. doi: 10.1111/bjd.18615.
    >> Share

  766. GARCIA-SOUTO F
    Recurrent headache and facial ecchymosis: a case of dermatitis artefacta? Reply from authors.
    Br J Dermatol. 2019 Nov 17. doi: 10.1111/bjd.18699.
    >> Share

  767. HU C, Nijsten T, Pasmans SGMA, de Jongste JC, et al
    Associations of eczema phenotypes with emotional and behavioural problems from birth until school age. The Generation R Study.
    Br J Dermatol. 2019 Nov 15. doi: 10.1111/bjd.18705.
    >> Share

  768. COIAS J, Marzuka A, Hosler GA, Chong BF, et al
    T cell polarization differs in various stages of discoid lupus erythematosus skin.
    Br J Dermatol. 2019 Nov 13. doi: 10.1111/bjd.18704.
    >> Share

  769. HOLLYWOOD A, O'Keeffe C, Boggs J, Feighery C, et al
    The Utility of Subcutaneous Methotrexate for Chronic Plaque Psoriasis in a Real-World Setting.
    Br J Dermatol. 2019 Nov 12. doi: 10.1111/bjd.18698.
    >> Share

  770. ARMSTRONG AW, Blauvelt A, Crowley JJ, Gordon KB, et al
    Defining drug-free remission of skin disease in patients with plaque psoriasis.
    Br J Dermatol. 2019 Nov 9. doi: 10.1111/bjd.18694.
    >> Share

  771. THAI D, Pinter A, Sebastian M, Termeer C, et al
    Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: Results from a randomised, active comparator-controlled phase 3b trial (POLARIS).
    Br J Dermatol. 2019 Nov 9. doi: 10.1111/bjd.18696.
    >> Share

  772. RENCZ F
    Cross-country generalizability of quality-of-life scores in atopic dermatitis.
    Br J Dermatol. 2019 Nov 8. doi: 10.1111/bjd.18601.
    >> Share

  773. TOBIN AM
    Unravelling the microbiome in psoriasis.
    Br J Dermatol. 2019 Nov 8. doi: 10.1111/bjd.18547.
    >> Share

  774. KLUGER N
    Recurrent headache and facial ecchymosis: a case of dermatitis artefacta?
    Br J Dermatol. 2019 Nov 8. doi: 10.1111/bjd.18691.
    >> Share

  775. HAYASHI A, Matsumoto K, Mitsuishi T
    Three cases of recalcitrant cutaneous warts treated with quadrivalent human papillomavirus vaccine: the HPV type may not determine the outcome.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18645.
    >> Share

  776. DEL REGNO L, Louveau B, Battistella M, Sadoux A, et al
    Clinical significance of BRAF/NRAS concurrent mutations in a clinic-based metastatic melanoma cohort.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18641.
    >> Share

  777. INAMURA E, Nishie W, Yamaguchi Y, Fujimura Y, et al
    Linear IgA/IgG bullous dermatosis with autoantibodies directing the native and processed forms of BP180.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18642.
    >> Share

  778. GJERSVIK P
    Why is the high risk of skin cancer in organ transplant recipients declining?
    Br J Dermatol. 2019;181:879-880.
    >> Share

  779. DUFFY DL, Lee KJ, Jagirdar K, Pflugfelder A, et al
    Naevus count and MC1R R alleles contribute to melanoma risk.
    Br J Dermatol. 2019;181:e119-e142.
    >> Share

  780. ALEXANDER H, Paller AS, Traidl-Hoffmann C, Beck LA, et al
    The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18643.
    >> Share

    October 2019
  781. AGUILAR JA, Irurzun AL, Bayona JIY, Rodriguez MA, et al
    Image Gallery: Zosteriform metastasis from melanoma.
    Br J Dermatol. 2019 Oct 30. doi: 10.1111/bjd.18567.
    >> Share

  782. DIELS J, Thilakarathne P, Cameron C, McElligott S, et al
    Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS Analysis.
    Br J Dermatol. 2019 Oct 25. doi: 10.1111/bjd.18634.
    >> Share

  783. SINGH P, Silverberg JI
    Under-screening of depression in United States outpatients with atopic dermatitis and psoriasis.
    Br J Dermatol. 2019 Oct 24. doi: 10.1111/bjd.18629.
    >> Share

  784. SHI KY, Kunzler E, Hynan LS, Chong BF, et al
    Autoimmune disease development before and after cutaneous lupus erythematosus diagnosis.
    Br J Dermatol. 2019 Oct 24. doi: 10.1111/bjd.18631.
    >> Share

  785. EGEBERG A, Griffiths CEM, Williams HC, Andersen YMF, et al
    Clinical characteristics, symptoms, and burden of psoriasis and atopic dermatitis in adults.
    Br J Dermatol. 2019 Oct 20. doi: 10.1111/bjd.18622.
    >> Share

  786. HOWARD M, Xie C, Wee E, Wolfe R, et al
    Acral lentiginous melanoma: differences in survival compared to other subtypes.
    Br J Dermatol. 2019 Oct 19. doi: 10.1111/bjd.18620.
    >> Share

  787. GRAN S
    Vitiligo and skin cancer: is it a question of ethnicity?
    Br J Dermatol. 2019 Oct 16. doi: 10.1111/bjd.18533.
    >> Share

  788. TOLAND AE
    Developing risk prediction models for melanoma: balancing better predictive value with ease of clinical implementation.
    Br J Dermatol. 2019 Oct 13. doi: 10.1111/bjd.18531.
    >> Share

  789. DEINLEIN T, Longo C, Schulter G, Pizzichetta MA, et al
    The prevailing dermoscopic vascular pattern in melanoma is influenced by tumor thickness and pigmentation type.
    Br J Dermatol. 2019 Oct 12. doi: 10.1111/bjd.18610.
    >> Share

  790. KATZMAN JA, Chavan R, Holliday A, Coman G, et al
    Mosaic Variant in ATP2C1 Presenting as Relapsing Linear Acantholytic Dermatosis: Case Report.
    Br J Dermatol. 2019 Oct 12. doi: 10.1111/bjd.18607.
    >> Share

  791. VAN TIGGELEN H, LeBlanc K, Campbell K, Woo K, et al
    Standardising the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel (ISTAP) Classification System in 44 countries.
    Br J Dermatol. 2019 Oct 12. doi: 10.1111/bjd.18604.
    >> Share

  792. CORK MJ, Thaci D, Eichenfield LF, Arkwright PD, et al
    Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension.
    Br J Dermatol. 2019 Oct 8. doi: 10.1111/bjd.18476.
    >> Share

  793. FREW JW, Navrazhina K
    No Evidence that Impaired Notch Signaling Differentiates Hidradenitis Suppurativa From Other Inflammatory Skin Diseases.
    Br J Dermatol. 2019 Oct 8. doi: 10.1111/bjd.18593.
    >> Share

  794. RUNDLE CW, Dellavalle RP
    Nonsteroidal anti-inflammatory drug associations with nonmelanoma skin cancer - the saga continues.
    Br J Dermatol. 2019;181:654-656.
    >> Share

    September 2019
  795. STROWD LC, Feldman SR
    Overcoming poor adherence is a major hurdle to managing atopic dermatitis.
    Br J Dermatol. 2019 Sep 30. doi: 10.1111/bjd.18455.
    >> Share

  796. ALEXEYEV O
    Psoriasis, gut and microbiome.
    Br J Dermatol. 2019 Sep 30. doi: 10.1111/bjd.18467.
    >> Share

  797. KATOH N, Kataoka Y, Saeki H, Hide M, et al
    Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials.
    Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18565.
    >> Share

  798. HEETFELD AB, Schill T, Schroder SS, Forkel S, et al
    Challenging a paradigm: Skin sensitivity to sodium lauryl sulfate is independent of atopic diathesis.
    Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18564.
    >> Share

  799. CLAESON M, Baade P, Brown S, Soyer HP, et al
    Clinicopathological factors associated with death from thin (</=1.00mm) melanoma.
    Br J Dermatol. 2019 Sep 28. doi: 10.1111/bjd.18560.
    >> Share

  800. THYSSEN JP, Halling-Sonderby AS, Wu JJ, Egeberg A, et al
    Pain severity and use of analgesic medication in adults with atopic dermatitis: a cross-sectional study.
    Br J Dermatol. 2019 Sep 25. doi: 10.1111/bjd.18557.
    >> Share

  801. KOSTAKI M, Plaka M, Stergiopoulou A, Kypreou K, et al
    Trends in epidemiology of melanoma in situ in Greece: Data from a melanoma reference center during the period 2000-2018.
    Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18551.
    >> Share

  802. DUMMER R, Guminksi A, Gutzmer R, Lear JT, et al
    Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase 2 randomised, double-blind BOLT study.
    Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18552.
    >> Share

  803. LIMMER AL, Wu JH, Doan HQ, Rady PL, et al
    Acquired epidermodysplasia verruciformis: a ten-year anniversary update.
    Br J Dermatol. 2019 Sep 23. doi: 10.1111/bjd.18549.
    >> Share

  804. RITCHIE S, Qureshi I, Molloy K, Yoo J, et al
    Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T cell lymphoma at a tertiary care centre: Should we avoid chemotherapy in conditioning regimes?
    Br J Dermatol. 2019 Sep 19. doi: 10.1111/bjd.18541.
    >> Share

  805. GIBSON JAG, Dobbs TD, Griffiths R, Song J, et al
    The Association of Smoking and Socioeconomic status on Cutaneous Melanoma: a population based, data linkage, case-control study.
    Br J Dermatol. 2019 Sep 17. doi: 10.1111/bjd.18526.
    >> Share

  806. ENGELINA S, Saggu M, Yoo J, Shah F, et al
    Brentuximab a novel antibody therapy: Real-World Use Confirms Efficacy and Tolerability for CD30 positive cutaneous lymphoma.
    Br J Dermatol. 2019 Sep 16. doi: 10.1111/bjd.18535.
    >> Share

  807. BUSTAMANTE M, Hernandez-Ferrer C, Tewari A, Sarria Y, et al
    Dose and time effects of solar simulated ultraviolet radiation on the in vivo human skin transcriptome.
    Br J Dermatol. 2019 Sep 16. doi: 10.1111/bjd.18527.
    >> Share

  808. CUST AE, Badcock C, Smith J, Thomas NE, et al
    A risk prediction model for development of subsequent primary melanoma in a population-based cohort.
    Br J Dermatol. 2019 Sep 14. doi: 10.1111/bjd.18524.
    >> Share

  809. PARDO LM, Hamer MA, Liu F, Velthuis P, et al
    Principal component analysis of seven skin ageing features identifies three main types of skin ageing.
    Br J Dermatol. 2019 Sep 13. doi: 10.1111/bjd.18523.
    >> Share

  810. SOLMAZ D, Bakirci S, Al Onazi A, Al Osaimi N, et al
    Musculoskeletal ultrasound can improve referrals from dermatology to rheumatology for patients with psoriasis.
    Br J Dermatol. 2019 Sep 10. doi: 10.1111/bjd.18515.
    >> Share

  811. GISONDI P
    Does systemic treatment of psoriasis reduce the risk of comorbidities?
    Br J Dermatol. 2019 Sep 9. doi: 10.1111/bjd.18456.
    >> Share

  812. KLOCZKO E, Maybury CM
    Secukinumab for treatment of nail psoriasis: results from the TRANSFIGURE trial.
    Br J Dermatol. 2019 Sep 9. doi: 10.1111/bjd.18439.
    >> Share

  813. SILVERBERG JI
    Atopic dermatitis epidemiology: moving beyond cross-sectional studies.
    Br J Dermatol. 2019 Sep 8. doi: 10.1111/bjd.18440.
    >> Share

  814. WANG Y, Jin H
    Image Gallery: Lichen planus pigmentosus of the tongue.
    Br J Dermatol. 2019 Sep 6. doi: 10.1111/bjd.18418.
    >> Share

  815. COLLANTES-RODRIGUEZ C, Jimenez-Gallo D, Ossorio-Garcia L, Villegas-Romero I, et al
    Image Gallery: Cutaneous ulcers in anti-MDA5 dermatomyositis successfully treated with sildenafil.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18376.
    >> Share

  816. KIMBALL AB, Papp KA, Reich K, Gooderham M, et al
    Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments, and switching from etanercept: results from phase 3 studies.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18484.
    >> Share

  817. BAILEY EE, Mayer JE, Geller AC, Johnson TM, et al
    Role of the partner/spouse in melanoma discovery and related health behaviors and practices.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18478.
    >> Share

  818. STILLER HT, Mikiver R, Uppugunduri S, Lindholm C, et al
    Health Related Quality of Life in Melanoma Patients - characterization of a Swedish cohort.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18486.
    >> Share

  819. BONSANG B, Brenaut E, Talagas M, Uguen A, et al
    Small-fiber neuropathy and pruritus: histological patterns of nerve fibers in skin biopsies.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18485.
    >> Share

  820. MUNTYANU A, Gulliver WP, Fleming P
    Weight Change in Patients with Psoriasis using Tumor Necrosis Factor-Alpha Inhibitors.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18483.
    >> Share

  821. ZHOU M, Wang H, Yang M, He C, et al
    Lipidomic analysis of facial skin surface lipid reveals the altered lipid profile in infancy acne.
    Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18474.
    >> Share

  822. KOPECKI Z
    Tumour serine proteases C1r and C1s as novel biomarkers and therapeutic targets in invasive sporadic and recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma.
    Br J Dermatol. 2019 Sep 4. doi: 10.1111/bjd.18419.
    >> Share

  823. HUANG YW, Tsai TF
    Juvenile onset Pustular Psoriasis: Case Series and Literature Review.
    Br J Dermatol. 2019 Sep 4. doi: 10.1111/bjd.18473.
    >> Share

  824. ROSENTHAL JM, Kim EJ
    Health-related quality of life in cutaneous T-cell lymphoma: examining all sides of the issue.
    Br J Dermatol. 2019 Sep 2. doi: 10.1111/bjd.18428.
    >> Share

  825. RONGIOLETTI F, Mugheddu C
    Image Gallery: Green moss-like psoriasis.
    Br J Dermatol. 2019 Sep 2. doi: 10.1111/bjd.18421.
    >> Share

    August 2019
  826. HABER RM
    Classifying primary paediatric cutaneous mucinoses.
    Br J Dermatol. 2019 Aug 29. doi: 10.1111/bjd.18431.
    >> Share

  827. YA J, Khanna U, Havele S, Fernandez AP, et al
    Utility of Repeat Latent Tuberculosis Testing with QuantiFERON-TB Gold test in Psoriasis Patients Treated with TNF-alpha inhibitors at a Single U.S. Institution.
    Br J Dermatol. 2019 Aug 27. doi: 10.1111/bjd.18461.
    >> Share

  828. DI ALTOBRANDO A, Patrizi A, Vara G, Merli Y, et al
    Topical zinc oxide: an effective treatment option for erosive pustular dermatosis of the leg.
    Br J Dermatol. 2019 Aug 25. doi: 10.1111/bjd.18453.
    >> Share

  829. ANDERSEN L, Nyeland ME, Nyberg F
    Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the UK and the US.
    Br J Dermatol. 2019 Aug 22. doi: 10.1111/bjd.18451.
    >> Share

  830. GOLDINGER SM, Valeska Matter A, Urner-Bloch U, Narainsing J, et al
    Binimetinib in heavily pretreated NRAS-mutant Melanoma Patients with Brain Metastases.
    Br J Dermatol. 2019 Aug 22. doi: 10.1111/bjd.18449.
    >> Share

  831. ISHIDA-YAMAMOTO A
    The basket-weave pattern is present in the skin for a reason.
    Br J Dermatol. 2019 Aug 21. doi: 10.1111/bjd.18375.
    >> Share

  832. SINGH S, Rao M, Verma A
    Image Gallery: Mutilating diffuse cutaneous leishmaniasis in AIDS.
    Br J Dermatol. 2019 Aug 20. doi: 10.1111/bjd.18367.
    >> Share

  833. LEE KJ, Soyer HP
    Smartphones, artificial intelligence and digital histopathology take on basal cell carcinoma diagnosis.
    Br J Dermatol. 2019 Aug 19. doi: 10.1111/bjd.18374.
    >> Share

  834. BELLONI FORTINA A, Caroppo F
    Severe childhood psoriasis: need for safety and efficacy data on long-term treatment with biologics.
    Br J Dermatol. 2019 Aug 18. doi: 10.1111/bjd.18362.
    >> Share

  835. AICHELBURG MC, Tanew A
    Secukinumab without the initial loading dose in the treatment of plaque-type psoriasis - a simplified dosing regimen at the expense of efficacy?
    Br J Dermatol. 2019 Aug 18. doi: 10.1111/bjd.18355.
    >> Share

  836. OLSSON M, Bajpai R, Wee LWY, Yew YW, et al
    The cost of childhood atopic dermatitis in a multi-ethnic Asian population: a cost-of-illness study.
    Br J Dermatol. 2019 Aug 17. doi: 10.1111/bjd.18442.
    >> Share

  837. RENCZ F, Gulacsi L, Pentek M, Szegedi A, et al
    DLQI-R scoring improves the discriminatory power of Dermatology Life Quality Index in psoriasis, pemphigus and morphea patients.
    Br J Dermatol. 2019 Aug 16. doi: 10.1111/bjd.18435.
    >> Share

  838. SHEEN YS, Tan KT, Tse KP, Liao YH, et al
    Genetic Alterations in Primary Melanoma in Taiwan.
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18425.
    >> Share

  839. WOLLENBERG A, Beck LA, Blauvelt A, Simpson EL, et al
    Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18434.
    >> Share

  840. DENG PH, Wang CJ, Armstrong AW
    An Association between Hidradenitis Suppurativa and HIV.
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18433.
    >> Share

  841. GOUIN O, Misery L
    Thymic stromal lymphopoietin, protease-activated receptor 2 and interleukin 1 are involved in the relationship between skin irritation and atopic dermatitis.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18315.
    >> Share

  842. PUIG L
    Significant weight loss improves and prevents psoriasis and psoriatic arthritis in obese patients: a Critically Appraised Topic and a call to action.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18322.
    >> Share

  843. HAIDARI W, Feldman SR
    Rates of psoriasis in patients with palmoplantar pustulosis.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18314.
    >> Share

  844. CHABY G, Maldini C, Haddad C, Lebrun-Vignes B, et al
    Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-2016: a four-source capture-recapture estimate.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18424.
    >> Share

  845. BYRNE N, Hughes R, Murphy LA, Kirby B, et al
    Remission of severe hidradenitis suppurativa following chemotherapy for Hodgkin's lymphoma.
    Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18423.
    >> Share

  846. LEBWOHL M
    A new era in the treatment of atopic dermatitis.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18349.
    >> Share

  847. ODUM N
    Deregulated signalling and inflammation in cutaneous T-cell lymphoma.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18353.
    >> Share

  848. DARRIGADE AS, Milpied B, Seneschal J
    Image Gallery: Jacquet papulo-erosive dermatitis in an adult.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18346.
    >> Share

  849. GROMA G
    Oxymatrine may represent an additional therapeutic tool in severe plaque psoriasis management.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18299.
    >> Share

  850. SOURA E, Stratigos A
    Implementing polygenic risk scores in skin cancer: a step towards personalized risk prediction.
    Br J Dermatol. 2019 Aug 7. doi: 10.1111/bjd.18324.
    >> Share

  851. CLAUSEN ML, Agner T
    The inhabitants of our skin.
    Br J Dermatol. 2019 Aug 6. doi: 10.1111/bjd.18312.
    >> Share

  852. FEARFIELD L, Nobbs J, Petruckevitch A, Harland C, et al
    Severe vitamin D deficiency associated with BRAF mutated melanoma.
    Br J Dermatol. 2019 Aug 5. doi: 10.1111/bjd.18413.
    >> Share

  853. VUONG K, Armstrong BK, Drummond M, Hopper JL, et al
    Development and external validation study of a melanoma risk prediction model incorporating clinically-assessed naevi and solar lentigines.
    Br J Dermatol. 2019 Aug 4. doi: 10.1111/bjd.18411.
    >> Share

  854. REICH K, Augustin M, Thaci D, Pinter A, et al
    A 24-week multicentre, randomised, open-label, parallel-group study comparing the efficacy and safety of ixekizumab to fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment.
    Br J Dermatol. 2019 Aug 3. doi: 10.1111/bjd.18384.
    >> Share

  855. WANG X, Sun J
    Image Gallery: Acquired cutaneous lymphangiectasia secondary to rectal cancer treatment.
    Br J Dermatol. 2019;181:e36.
    >> Share

  856. ELDER DE, Barnhill RL
    The pink papules and plaques of Spitz.
    Br J Dermatol. 2019;181:235.
    >> Share

  857. MOTLEY R, Arron S
    Mohs micrographic surgery for cutaneous squamous cell carcinoma.
    Br J Dermatol. 2019;181:233-234.
    >> Share

  858. FELMINGHAM C, Yip L, Tam M, Nixon RL, et al
    Allergy to sunscreen and leave-on facial products is not a likely causative mechanism in frontal fibrosing alopecia - perspective from contact allergy experts.
    Br J Dermatol. 2019 Aug 1. doi: 10.1111/bjd.18380.
    >> Share

    July 2019
  859. ANDERSEN YMF, Egeberg A
    Seborrhoeic dermatitis - understood or understudied?
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18307.
    >> Share

  860. THONGPRASOM K
    Challenges in using topical calcineurin inhibitors as a treatment for recalcitrant oral lichen planus.
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18304.
    >> Share

  861. SZEGEDI A
    Connections between atopic dermatitis and ageing.
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18306.
    >> Share

  862. GAMBICHLER T, Schroter U, Hoxtermann S, Susok L, et al
    Decline of PD-1 positive circulating T regulatory cells predicting more favorable clinical outcome of melanoma patients under immune checkpoint blockade.
    Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18379.
    >> Share

  863. RIBERO S
    Synergy between MC1R mutations and a high naevus count in increasing melanoma risk in the general population.
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18301.
    >> Share

  864. CHENG L
    Precision dosage of methotrexate in psoriasis.
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18273.
    >> Share

  865. BERNIGAUD C, Chosidow O
    Are swabs an appropriate way to sample for skin microbiome research?
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18257.
    >> Share

  866. VAN DEN REEK JMPA
    Predicting treatment success with biologics in psoriasis.
    Br J Dermatol. 2019 Jul 28. doi: 10.1111/bjd.18251.
    >> Share

  867. NICHOLAS MN, Drucker AM
    Depression and anxiety in atopic dermatitis: increasing recognition and opportunities to intervene.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18252.
    >> Share

  868. QIAN YT, Vano-Galvan S, Liu JW, Liu W, et al
    Image Gallery: Multiple yellowish papules and verrucous plaques on the vulva.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18243.
    >> Share

  869. ANDERSEN YMF, Egeberg A
    Comparing apples, oranges and atopic dermatitis.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18303.
    >> Share

  870. MAILHE M, Tissot-Dupont H, Lagier JC
    Image Gallery: Atypical rash in an HIV-infected woman.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18242.
    >> Share

  871. LEVY M, Martin L, Bursztejn AC, Chiaverini C, et al
    Ivermectin safety in infants and children under 15 kg treated for scabies: A multicentric Observational study.
    Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18369.
    >> Share

  872. RAMASAMY S, Barnard E, Dawson TL Jr, Li H, et al
    The role of the skin microbiota in acne pathophysiology.
    Br J Dermatol. 2019 Jul 24. doi: 10.1111/bjd.18230.
    >> Share

  873. BOTTESI G, Spoto A, Trevisson E, Zuccarello D, et al
    Dysfunctional coping is related to impaired skin-related QoL and psychological distress